EurekaMag PDF full texts Chapter 35,955

Kirito, K.; Fox, N.; Kaushansky, K. 2004: Thrombopoietin induces HOXA9 nuclear transport in immature hematopoietic cells Potential mechanism by which the hormone favorably affects hematopoietic stem cells. Molecular and Cellular Biology. 24(15): 6751-6762, Ust

Perlingeiro, R.C.R.; Kyba, M.; Daley, G.Q. 2001: Thrombopoietin is a growth factor for the hemangioblast. Blood 98(11 Part 1): 71a-72a

Verstegen, M.M.A.; Wognum, A.W.; Wagemaker, G. 2000: Thrombopoietin is a major limiting factor for selective outgrowth of human umbilical cord blood cells in NOD/SCID recipient mice. Blood 96(11 Part 2): 128b-129b

Ballmaier, M.; Germeshausen, M.; Krukemeier, S.; Welte, K. 2003: Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia. Annals of the new York Academy of Sciences 996: 17-25

Guida, J.D.; Reilly, M.P.; Paul, D.A.; Mckenzie, S.E. 2002: Thrombopoietin levels are decreased in a mouse model of E coli induced thrombocytopenia/DIC. Journal of Investigative Medicine 50(2): 184A

Wang, Y.an Jen; Hsiu, Hwei Chih; Chau, Gar Yang 1999: Thrombopoietin levels in patients with hepatitis B virus related liver cirrhosis. Hepatology 30(4 Part 2): 433A

Kim, J.H.; Yeon, J.; Kim, J.S.; Park, S.; Kwon, O.; Kong, H.; Bak, Y.; Byun, K.; Lee, C. 2001: Thrombopoietin may not play an important role in change of platelets in chronic hepatitis B patients with thrombocytopenia treated by lamivudine. Journal of Hepatology 34(Suppl 1): 174-175

Howarth, L.J.; Mccloy, M.P.; Murray, N.A.; Roberts, I.A.G. 2000: Thrombopoietin mimetic peptide is a potent stimulant of human megakaryocyte colony production. Blood 96(11 Part 1): 676a-677a

Luengo, J.I.; Duffy, K.J.; Miller, S.G. 2003: Thrombopoietin mimetics. Official Gazette of the United States Patent and Trademark Office Patents 1277(5)

Geddis, A.E.; Fox, N.E.; Kaushansky, K. 2003: Thrombopoietin promotes platelet recovery from a myelosuppressive regimen by mechanisms that are independent of p53. Blood 102(11): 353a

Rouleau, C.; Feldman, L. 1999: Thrombopoietin promotes the growth and proliferation of cells bearing the erythropoietin receptor but lacking the thrombopoietin receptor. Blood 94(10 Suppl 1 Pt 2): 150b-151b

Wetzler, M.; Baer, M.R. 1999: Thrombopoietin receptor in acute myeloid leukemia. Leukemia Research 23(2): 191-194

Paul, D.A.; Leef, K.H.; Taylor, S.; Mckenzie, S. 2000: Thrombopoietin response in infants with sepsis and thrombocytopenia. Pediatric Research 47(4 Part 2): 335A

Paulus, J.M.; Debili, N.; Larbret, F.; Levin, J.; Vainchenker, W. 2003: Thrombopoietin responsiveness reflects the number of doublings undergone by human megakaryocyte progenitors. Blood 102(11): 140b-141b

Fah, M.; Nydegger, U.E. 2000: Thrombopoietin serum concentration transiently spikes a few days after liver transplantation. Vox Sanguinis 78(Suppl 1): P254

Tacke, F.; Schoffski, P.; Ganser, A.; Manns, M.P.; Trautwein, C. 2002: Thrombopoietin serum levels are elevated in patients with chronic virus hepatitis and controlled on a post-transcriptional level. Journal of Hepatology 36(Suppl 1): 16-17

Spivak, J.; Moliterno, A. 2000: Thrombopoietin signaling defect in polycythemia vera platelets. Official Gazette of the United States Patent and Trademark Office Patents 1231(4)

Petrai, I.; Romanelli, R.G.; Bonacchi, A.; Efsen, E.; Pagliai, G.; Grossi, A.; Gentilini, P.; Laffi, G.; Marra, F. 2002: Thrombopoietin stimulates migration and invasion of HepG2 cells. Journal of Hepatology 36(Suppl 1): 82

Hao, Q.L.; Zhu, Y.; Price, M.A.; Zielinska, E.; Payne, K.J.; Crooks, G.M. 2003: Thrombopoietin supports B lymphopoiesis from pluripotent and lymphoid-restricted progenitors. Blood 102(11): 564a-565a

Jang, G.; Jin, H.; Seoh, J.; Im, S.; Ryu, K.; Park, H.Y. 2002: Thrombopoietin-induced apoptosis during ex vivo expansion of human cord blood CD34+ cells. Experimental Hematology (Charlottesville) 30(6 Suppl 1): 53

Oda, A.; Miyakawa, Y.; Druker, B.J.; Ozaki, K.; Ohashi, H.; Kato, T.; Miyazaki, H.; Handa, M.; Ikebuchi, K.; Ikeda, Y. 1999: Thrombopoietin-induced signal transduction and potentiation of platelet activation. Thrombosis and Haemostasis 82(2): 377-384

Alikhan, R.; Osborne, I.; Wilmott, R.; Vaughan, P.; Lomas, C.; Cohen, A. 2002: Thromboprohylaxis in general medical patients Low molecular weight heparin versus unfractionated heparin. British Journal of Haematology 117(Suppl 1): 23

Vossen, C.; Conard, J.; Fontcuberta, J.; Jonge, I.D.; Makris, M.; Meer, F.V.n Der; Pabinger, I.; Palareti, G.; Preston, F.; Scharrer, I.; Souto, J.; Svensson, P.; Walker, I. 2002: Thromboprophylaxis Reduces the Risk of Fetal Loss in Women with Hereditary Thrombophilia. Blood 100(11): Abstract No. 1044

Bick, R.L.; Haas, S. 2003: Thromboprophylaxis and thrombosis in medical, surgical, trauma, and obstetric/gynecologic patients. Hematology/Oncology Clinics of North America 17(1): 217-258

Goonewardena, S.A. 2001: Thromboprophylaxis as routine for Sri Lankan surgical patients: where is the evidence?. Ceylon Medical Journal 46(2): 75-76

Hellgren, M.; Dahlgren, E.; Hanson, A.; Tengborn, L. 2000: Thromboprophylaxis during hysterectomy. Haemostasis 30(1-2): 51-52

Aygoeren Puersuen, E.; Krause, M.; Ludwig, G.; Sohn, C.; Scharrer, I. 1999: Thromboprophylaxis during pregnancy in women with thrombophilic disorders. Annals of Hematology 78(Suppl 1): A50

Ellison, J.; Thomson, A.J.; Walker, I.D.; Greer, I.A. 2000: Thromboprophylaxis following caesarean section Comparison of the anti-factor Xa activities of three commonly used low molecular weight heparins. Journal of Obstetrics and Gynaecology (Abingdon) 20(Suppl 1): S39-S40

Pather, S.; Sykes, P.; Davis, R.; Reid, R.; Skjellerup, N. 2001: Thromboprophylaxis following caesarean section; hospital protocols are necessary. New Zealand Medical Journal 114(1136): 339-340

Mismetti, P.; Laporte, S. 2002: Thromboprophylaxis in acute medical patients: need for an implementation strategy. Haematologica 87(7): 673-675

Van Schil, P.E. 2002: Surgical treatment for pulmonary metastases. Acta Clinica Belgica 57(6): 333-339

Anonymous 2000: Thromboprophylaxis in hip fracture surgery: a pilot study comparing danaparoid, enoxaparin and dalteparin. The TIFDED Study Group. Haemostasis 29(6): 310-317

Nurmohamed, M.T. 2000: Thromboprophylaxis in neurosurgical patients. Seminars in Hematology 37(3 Suppl 5: 15-18

Monreal, M. 2003: Thromboprophylaxis in patients undergoing major orthopedic surgery Is there a need for new drugs?. Methods and Findings in Experimental and Clinical Pharmacology 25(Suppl A): 81

Borris, L.C.; Lassen, M.R.; Breindahl, M.; Jensen, H.P. 2002: Thromboprophylaxis with Enoxaparin Versus Unfractionated Heparin in Elderly Patients with Acute Hip Fracture Survival at Eight to Ten Years. Blood 100(11): Abstract No. 2758

Turpie, A.G.; Cohen, A.T.; Olsson, C.G.; Vaitkus, P.T.; Goldhaber, S.Z.; Leizorovicz, A.; The Prevent Medical Thromboprophylaxis Study Group 2004: Thromboprophylaxis with dalteparin reduces clinically important venous thromboembolism in patients with congestive heart failure. Journal of the American College of Cardiology 43(5 Suppl A): 501A

Mätzsch, T. 2000: Thromboprophylaxis with low-molecular-weight heparin: economic considerations. Haemostasis 30(Suppl 2): 141-145; Discussion: 128-129

Shah, C.B.; Wolfgang, L.L. 2001: Thromboresistant coated medical device. Official Gazette of the United States Patent and Trademark Office Patents 1247(3)

Lu, T.; Tomczuk, B.E.; Markotan, T.P. 2003: Thromboresistant materials incorporating pyrazinone protease inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1267(1)

Wilson, J.E. 2000: Thromboresistant plastic article and method of manufacture. Official Gazette of the United States Patent and Trademark Office Patents 1233(3)

Rebolledo, M.A.; Perloff, J.K. 1999: Thrombosed pulmonary arterial aneurysm in Eisenmenger's syndrome. Clinical Cardiology 22(2): 127

Tabibian, L.; Ginsberg, D.A. 2003: Thrombosed urethral hemangioma. Journal of Urology 170(5): 1942

Tisman, G. 2001: Thromboses after estrogen hormone replacement, progesterone or tamoxifen therapy in patients with elevated blood levels of homocysteine. American Journal of Hematology 68(2): 135

Donahue, B.S. 2002: Thrombosis after deep hypothermic circulatory arrest with antifibrinolytic therapy: is factor V leiden the smoking gun?. Anesthesiology 97(3): 760

Hirsh, J.; Weitz, J.I. 1999: Thrombosis and anticoagulation. Seminars in Hematology 36(4 Suppl. 7): 118-132

Biron Andreani, C.; Mallol, C.; Vergnes, C.; Benattar, N.; Schved, J.F. 2002: Thrombosis and antiphospholipid antibodies in non-SLE patients Predictive value of antiphosphatidylserine antibodies. Pathophysiology of Haemostasis and Thrombosis 32(4): 194

Fischer, A.; Gutstein, D.E.; Fuster, V. 1999: Thrombosis and coagulation abnormalities in the acute coronary syndromes. Cardiology Clinics 17(2): 283-294 Viii

Michaels, L.A.; Maraventano, M.F.; Drachtman, R.A. 2003: Thrombosis and gangrene in a patient with sickle cell disease and dactylitis. Journal of Pediatrics 142(4): 449

Gupta, S.; Mccune, W.J.; Kaplan, M.J.; Mcdonagh, K.T.; Schmaier, A.H.; Crofford, L.J. 1999: Thrombosis and ischemia in patients with systemic lupus erythematosus treated with celecoxib A series of two cases. Arthritis and Rheumatism 42(9 Suppl): S149

Falanga, A. 2003: Thrombosis and malignancy: an underestimated problem. Haematologica 88(6): 607-610

Maree, A.O.; Cox, D. 2004: Thrombosis and nitric oxide donor drugs. Thrombosis and Haemostasis 91(5): 848-850

Becker, R.C. 1999: Thrombosis and the role of the platelet. American Journal of Cardiology 83(9a): 3e-6e

Whitcher, F.D.; Kaganov, A.; Thornton, S.C. 2001: Thrombosis filter having a surface treatment. Official Gazette of the United States Patent and Trademark Office Patents 1249(2)

Gurgey, A.; Gumruk, F.; Ozyurek, E.; Celiker, A.; Ozkutlu, S.; Ozer, S.; Bilgic, A.; Ozme, S. 2001: Thrombosis in children with cardiac pathology. Blood 98(11 Part 2): 89b-90b

Mauri, M.; Ordi Ros, J.; Paredes, F.; Villarreal, J.; Balada, E.; Vilardell, M. 2002: Thrombosis in lupus patients Antiphospholipid antibodies, anti-inhibitor protein antibodies of blood coagulation, and non immune risk factors study. Lupus 11(9): 606

Ordi Ros, J.; Mauri, M.; Paredes, J.; Bujan, S.; Matas, L.; Vilardell, M. 2001: Thrombosis in patients with lupus Immune and non-immune risk factors. Lupus 10(Suppl 1): S24

Knoefler, R.; Siegert, E.; Lauterbach, I.; Taut Sack, H.; Siegert, G.; Gehrisch, S.; Reichelt, D.; Heubner, G.; Rupprecht, E.; Kabus, M. 1999: Thrombosis in pediatric oncologic patients with central venous lines - importance of inherited thrombophilic risk factors. Annals of Hematology 78(Suppl 1): A29

Salazar Sanchez, L.; Navarrete, M.; Cartin, M.; Carrillo, J.M.I.; Jimenez Arce, G.; Herrmann, F.H. 2003: Thrombosis in pediatric patients of Costa Rica-first report. Blood 102(11): 113b

Von Tempelhoff, G.F.; Heilmann, L.; Hommel, G.; Schneider, D.; Niemann, F. 1999: Thrombosis incidence and the risk to die of cancer - A prospective follow-up study in 451 patients with primary gynecologic cancer. Annals of Hematology 78(Suppl 1): A26

Von Tempelhoff, G.F.; Heilmann, L.; Hommel, G.; Schneider, D.; Niemann, F. 1999: Thrombosis incidence and the risk to die of cancer - A prospective follow-up study in patients with non-metastatic breast cancer. Breast Cancer Research and Treatment 57(1): 99

Vazquez-Jimenez, J.F.; Janssens, U.; Sellhaus, B.; Hermanns, B.; Huegel, W.; Hanrath, P.; Messmer, B.J. 1999: Thrombosis of a mitral valve prosthesis in a patient with heparin-induced thrombocytopenia type Ii. Journal of Thoracic and Cardiovascular Surgery 118(4): 751-753

Obergfell, A.; Langenfeld, H.; Hopp, H.; Steigerwald, U.; Grossmann, R. 2004: Thrombosis of a prosthetic aortic valve during pregnancy despite therapeutic dosage of Nadroparin. Thrombosis and Haemostasis 91(4): 839-840

Miljić, P.; Colović, M.D.; Suvajdzić, N. 2000: Thrombosis of lienal vein and acute consumptive coagulopathy following warfarin administration in a patient with severe protein C deficiency. European Journal of Haematology 64(2): 130-131

Parker, H.H.; Bynoe, R.P.; Nottingham, J.M. 2003: Thrombosis of the portal venous system after splenectomy for trauma. Journal of Trauma 54(1): 193-196

Bonofiglio, R.; Mollica, A.; Tosti, F.; Vocaturo, G.; De Napoli, N. 1999: Thrombosis of the superior vein cava in uremic chronic patient in haemodialysis, without vascular access and performing hydrotorax post-CAPD Therapeutic dilemma. Nephrology Dialysis Transplantation 14(9): A174

Van't Veer, C.; Kalafatis, M.; Mann, K.G. 1999: Thrombosis prophylaxis for factor VLEIDEN carriers. Official Gazette of the United States Patent and Trademark Office Patents 1228(1)

Yasin, Z.; Retzinger, G.; Palascak, J. 2001: Thrombosis refractory to urokinase in a patient with PNH and factor V Leiden mutation Is there a role for plasmaphersis?. Blood 98(11 Part 2): 101b-102b

Mougiou, A.; Karakantza, M.; Stavropoulou, F.; Theodori, H.; Maniatis, A. 2002: Thrombosis risk in individuals heterozygous or homozygous for the FVG1691A, FIIG20210A and MTHFRC677T polymorphisms in a Greek population. Vox Sanguinis 83(Suppl 2): 60-61

Kelsey, L.J.; Fry, D.M.; VanderKolk, W.E. 2000: Thrombosis risk in the trauma patient. Prevention and treatment. Hematology/Oncology Clinics of North America 14(2): 417-430

Hentschel, R.; Wieschulek, U. 1999: Thrombosis, embolism and related side effects of arterial and venous catheters - a study in infants. Annals of Hematology 78(Suppl 1): A8

Pinedo, H.M. 2003: Thrombosis, prevalence and new evidence on current perceptions of risk. Cancer Treatment Reviews 29(Suppl 2): 3-5

Rittersma, Z.H.; Boekholdt, S.M.; Koch, K.T.; Bax, M.; Schotborgh, C.E.; Piek, J.J.; Reitsma, P.H.; De Winter, R.J. 2003: Thrombospindin-4 gene polymorphism predicting Ala387Pro is associated with an increased risk of angiographic coronary in-stent restenosis. European Heart Journal 24(Abstract Suppl): 88

Breitkopf, K.; Gressner, A.M. 2002: Thrombospondin -1 and TSP-2 are potential modulators of TGF-beta1 activity in liver fibrogenesis. Hepatology 36(4 Part 2): 480A

Ren, G.; Mendoza, L.H.; Jackson, P.; Michael, L.H.; Smith, C.W.; Entman, M.L.; Frangogiannis, N.G. 2002: Thrombospondin -1 expression in the border zone of healing myocardial infarcts may suppress angiogenesis preventing infarct expansion. FASEB Journal 16(5): A856

Sid, B.; Sartelet, H.; Bellon, G.; El Btaouri, H.; Rath, G.; Delorme, N.; Haye, B.; Martiny, L. 2004: Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth. Critical Reviews in Oncology/Hematology 49(3): 245-258

Kuwashima, R.; Katano, T.; Takeo, E.; Katsumoto, M.; Toyota, Y.; Hayashi, K.; Matsuura, H.; Shingu, T. 2001: Thrombospondin 1 induces apoptosis of human endothelial cells through activation of p38 mitogen activated protein kinase. Journal of the American College of Cardiology 37(2 Suppl A): 283A

Velasco, P.; Huegel, R.; Harder, J.; Christophers, E.; Schroder, J.M.; Lawler, J.; Detmar, M.; Lange Asschenfeldt, B. 2004: Thrombospondin 1 modulates inflammation and vascular remodeling during experimental delayed-type hypersensitivity reactions. Journal of Investigative Dermatology 122(3): A4

Velasco, P.; Huegel, R.; Harder, J.; Christophers, E.; Schroder, J.M.; Lawler, J.; Detmar, M.; Lange Asschenfeldt, B. 2004: Thrombospondin 1 modulates inflammation, vascular leakage and vascular remodeling during experimental delayed-type hypersensitivity reactions. Journal of Investigative Dermatology 123(2)

Cleutjens, J.P.M.; Huynen, F.; Smits, J.F.M.; Bornstein, P.; Daemen, M.J.A.P. 1999: Thrombospondin 2 deficiency in mice results in cardiac rupture early after myocardial infarction. Circulation 100(18): 1; 56

Kijima, H.; Tokunaga, T.; Oshika, Y.; Fukushima, Y.; Nakamura, M.; Tomil, Y.; Yamazaki, H.; Tamaoki, N.; Ueyama, Y. 1999: Thrombospondin 2 gene expression is angiostatic and anti-metastasis factor of colon cancer. Proceedings of the American Association for Cancer Research Annual Meeting 40: 556

Armstrong, L.C.; Hankenson, K.D.; Bjorkblom, B.; Siadek, A.; Bornstein, P. 2001: Thrombospondin 2 is a paracrine, fibroblast-derived inhibitor of endothelial cell proliferation. Molecular Biology of the Cell 12(Suppl): 64a-65a

Dawson, D.W.; Bouck, N.P. 1999: Thrombospondin as an inhibitor of angiogenesis. Teicher, B A Cancer Drug Discovery and Development Series, 3; Antiangiogenic agents in cancer therapy 185-203

Van Laer, A.; Dallalio, G.; Means, R.T.Jr 2000: Thrombospondin enhances erythroid colony formation in vitro. Experimental Hematology 28(7 Suppl 1): 43

Breitkopf, K.; Sawitza, I.; Gressner, A.M. 2003: Thrombospondin expression in transdifferentiating hepatic stellate cells from rat liver Involvement in the activation of latent TGF-beta?. Journal of Hepatology 38(Suppl 2): 77

Reiher, F.K.; Volpert, O.; Crawford, S.E.; Bouck, B.P.; Campbell, S.C.; Henkin, J.; Dinney, C.P. 2001: Thrombospondin peptide mimetics inhibit bladder cancer growth by blocking angiogenesis via CD36. Journal of Urology 165(5 Suppl): 117

Frazier, W.A.; Kosfeld, M.D. 2002: Thrombospondin receptor binding peptides. Official Gazette of the United States Patent and Trademark Office Patents 1263(4)

Li, K.K. Har; Yang, M.; Chik, K.W.; Li, C.K.; Shing, M.M.K.; Fok, T.F.; Lee, S.M.; Lam, H.K. Bong; Yuen, P.M.P. 2002: Thrombospondin-1 Induces Apoptosis of Primary Leukemia Cells and Cell Lines. Blood 100(11): Abstract No. 4363

Beppu, R.; Nakamura, K.; Miyajima Uchida, H.; Kuroki, M.; Kuroki, M. 2000: Thrombospondin-1 acts as immunosuppressive modulator in cell-to-cell immune reaction. FASEB Journal 14(6): A1111

Kodama, J.; Hashimoto, I.; Seki, N.; Hongo, A.; Yoshinouchi, M.; Okuda, H.; Kudo, T. 2001: Thrombospondin-1 and -2 messenger RNA expression in invasive cervical cancer: correlation with angiogenesis and prognosis. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(9): 2826-2831

Plouet, J.; Ortega, N. 1999: Thrombospondin-1 and collagen IV are extracellular matrix binding sites for VEGF. IOVS Investigative Ophthalmology and Visual Science 40(4): S574

Narizhneva, N.V.; Topol, E.; Byzova, T. 2002: Thrombospondin-1 and functional consequences of its polymorphisms. Circulation 106(19): II108-II109

Rice, A.J.; Steward, M.A.; Horgan, K.; Benson, E.A.; Quinn, C.M. 1999: Thrombospondin-1 expression and angiogenesis in ductal carcinoma in situ of the breast. Journal of Pathology 187(Suppl): 26A

Wang, X.J.; Willis, A.I.; Kito, H.; Tuszynski, G.P.; Sumpio, B.E.; Gahtan, V. 1999: Thrombospondin-1 induces p38 activation in vascular smooth muscle cells. FASEB Journal 13(4 Part 1): A46

Zhao, X.M.; Hu, Y.; Mitchell, R.N.; Liao, J.K.; Libby, P. 2000: Thrombospondin-1 inhibits endothelial nitric oxide synthase expression in EC through TSP-1/CD36 binding. Circulation 102(18): 2; 16

Suzuki, J.I.; Zhao, X.M.; Cole, S.E.; Batirel, S.; Lawler, J.; Libby, P.; Mitchell, R.N. 2001: Thrombospondin-1 is an important mediator of intimal hyperplasia in allograft arteriopathy. Circulation 104(17): 2; 16

Zakrzewicz, Andreas; Bongrazio, Mauro; Da Silva Azevedo, Luis; Bergmann, Ernst C.; Pries, Axel R. 2004: Thrombospondin-1 is differentially regulated during shear stress-induced angiogenesis. FASEB Journal 18(4-5): Abstract 828

Cramer, T.; Schuppan, D.; Riecken, E.O.; Stefan, R. 1999: Thrombospondin-1 is overexpressed by mesenchymal cells in human pancreatic adenocarcinoma. Gastroenterology 116(4 Part 2): A1116

Sheibani, N. 2001: Thrombospondin-1 is present in vitreous and aqueous humor and is modulated by hyperglycemia. IOVS Investigative Ophthalmology and Visual Science 42(4): S243

Khoury, H.; Yamada, H.; Pavich, D.; Mechetner, E.; Burger, R.; Monk, B.; Fruehauf, J.P. 1999: Thrombospondin-1 may regulate angiogenesis in cervical carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 40: 456-457

Jurk, K.; Clemetson, K.J.; Van Aken, H.; Glauner, M.; Brodde, M.; Kehrel, B.E. 2001: Thrombospondin-1 mediates the association of monocytes to non activated platelets via GPIb. Annals of Hematology 80(Suppl 1): A31

Haviv, F.; Bradley, M.; Kalvin, D.; Schneider, A.; Majest, S.; Bell, R.; Davidson, D.; Haskell, C.; Marsh, K.; Nguyen, B.; Record, R.D.; Hodde, J.; Badylak, S.F.; Wang, Y.C.; Frost, D.; Henkin, J. 2002: Thrombospondin-1 mimetic peptides as inhibitors of angiogenesis. Proceedings of the American Association for Cancer Research Annual Meeting 43: 739

Margosio, B.; Vergani, V.; Borsotti, P.; Giavazzi, R.; Taraboletti, G. 2001: Thrombospondin-1 modulates angiogenic factors interaction with the extracellular matrix A potential mechanism of TSP-1 antiangiogenic activity. Haemostasis 31(Suppl 1): 84

Wang, T.N.; Albo, D.; John, A.; Tuszynski, G.P. 2000: Thrombospondin-1 modulates tumor cell invasion by upregulating matrix metalloproteinase-9 in breast cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 41: 131

Bonnefoy, Arnaud; Daenens, Kim; De Vos, Rita; Lawler, Jack; Hoylaerts, Marc F. 2003: Thrombospondin-1 null mice manifest defective platelet recruitment on activated endothelium and reduced thrombus anchoring on damaged vessel walls. Blood 102(11): 10a

Hawighorst, T.; Velasco, P.; Streit, M.; Detmar, M. 2001: Thrombospondin-1 overexpression in the skin of transgenic mice suppresses tumor development, growth and metastasis. Journal of Investigative Dermatology 117(2): 390

Tsuchida, T.; Kijima, H.; Tokunaga, T.; Oshika, Y.; Hatanaka, H.; Morino, F.; Abe, Y.; Yamazaki, H.; Tamaoki, N.; Ueyama, Y.; Nakamura, M. 2000: Thrombospondin-1 receptor CD36 is correlated with decreased stromal vascularization in colon cancer. Proceedings of the American Association for Cancer Research Annual Meeting 41: 167

John, A.S.; Rothman, V.L.; Tuszynski, G.P. 1999: Thrombospondin-1 stimulates expression of integrin alpha6 in human breast carcinoma cells A downstream modulator of TSP-1 induced cellular adhesion. Proceedings of the American Association for Cancer Research Annual Meeting 40: 449

Walton, B.; Willerson, J.T.; Coresh, J.; Boerwinkle, E. 2003: Thrombospondin-2 and lymphotoxin-alpha gene variations predict coronary heart disease in a large prospective study. Circulation 108(17): IV771

Yano, K.; Shirakata, Y.; Brown, L.F.; Bornstein, P.; Detmar, M. 2003: Thrombospondin-2 deficiency accelerates UVB-induced angiogenesis and cutaneous photo-damage. Journal of Investigative Dermatology 121(1): 0011

Streit, M.R.W.; Riccardi, L.; Velasco, P.; Brown, L.F.; Hawighorst, T.; Bornstein, P.; Detmar, M. 2000: Thrombospondin-2 is a novel endogenous inhibitor of tumor growth and angiogenesis. Journal of Investigative Dermatology 114(4): 751

Daniel, C.; Bornstein, P.; Hugo, C. 2001: Thrombospondin-2 knockout mice show an accelerated response to injury in experimental glomerulonephritis. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 701A-702A

Hong, Y.; Streit, M.; Oura, H.; Janes, L.; Riccard, L.; Detmar, M.; Hawighorst, T. 2002: Thrombospondin-2 overexpression in the skin of transgenic mice reduces the susceptibility to chemically induced multistep carcinogenesis. Journal of Investigative Dermatology 119(1): 217

Pluskota, E.; Stenina, O.I.; Krukovets, I.; Topol, E.J.; Plow, E.F. 2003: Thrombospondin-4 and human neutrophils The cardiovascular disease associated variant selectively elicits a pro-atherogenic response in these cells. Blood 102(11): 53a-54a

Brodde, M.F.; Glauner, M.; Van Aken, H.; Kehrel, B.E. 2001: Thrombospondin-heparin complexes induce platelet activation. Annals of Hematology 80(Suppl 1): A8

Stouffer, G.A.; Sajid, M.; Hu, Z. 1999: Thrombospondin-induced proliferation of vascular smooth muscle cells is mediated by integrin-associated protein. FASEB Journal 13(4 Part 1): A349

Bein, K.; Simons, M. 2000: Thrombospondins 1 and 2 inhibit activation of pro-metalloproteinases 2 and 9 enzymes. Circulation 102(18): 2; 174

Ma, H.; Huang, R.; Prieto, A.R.; Kahn, G.; Hage Korban, E.; Davis, J.; Schwartz, K.A.; Abela, G.S.; Schmaier, A.H.; Hasan, A.A.K. 2000: Thrombostatin, a PAR1 inhibitor, reduces both platelet aggregation and adhesion after arterial wall injury with balloon angioplasty. Journal of the American College of Cardiology 35(2 Suppl A): 281A

Journeycake, J.M.; Buchanan, G.R. 2002: Thrombotic Complications of Central Venous Catheters in 287 Children with Cancer. Blood 100(11): Abstract No. 1058

Chierichini, A.; Bartolini, M.; Persiani, M.; Ronci, B.; Iacovino, P.; Luzi, G.; Annino, L. 2002: Thrombotic Thrombocitopenic Purpura as Fatal Event after Engrafment in Allogenic Trasplantation for Acute Lymphoid Leukemia. Blood 100(11): Abstract No. 5369

Jajeh, A.; Ali, S.; Zalzaleh, G.; Hadad, L.; Abboud, W.; Singha, P. 2002: Thrombotic Thrombocytopenia Purpura in HIV Infection. Blood 100(11): Abstract No. 3660

Novo, A.; Gomez, D.; Duran, M.A.; Morey, M.; Guerra, J.M.; Campo, R.D.; Galmes, A.; Sampol, A.; Gutierrez, A.; Besalduch, J. 2002: Thrombotic Thrombocytopenic Purpura Description of 16 Patients in a Single Institution. Blood 100(11): Abstract No. 3792

Rock, G.; Lu, M.; Canadian Apheresis Group 2002: Thrombotic Thrombocytopenic Purpura Effects of Plasma Exchange with Cryosupernatant Plasma on Metalloprotease Levels in Plasma. Blood 100(11): Abstract No. 2804

Borghaei, H.; Cohen, S.D.; Mechanic, S.A.; Rubin, R.N. 2002: Thrombotic Thrombocytopenic Purpura in Solid Organ Transplantation Patients Clinical Findings, Therapy and Outcome. Blood 100(11): Abstract No. 2707

Dejong, A.T.; Womack, C.J.; Anderson, J.; Franklin, B.A. 2002: Thrombotic and fibrinolytic responses to resistance training in patients with coronary disease. Medicine and Science in Sports and Exercise 34(5 Suppl): S168

Montgomery, J.S.; Wolf, J.S.uart Jr 2004: Thrombotic and hemorrhagic complications associated with fractionated subcutaneous heparin vs sequential compression boots as deep venous thrombosis prophylaxis in patients undergoing urologic laparoscopy. Journal of Urology 171(4 Suppl): 392-393

Kampel, L.J. 2003: Thrombotic and hemorrhagic complications of prostate cancer Challenges in diagnosis and treatment. Pathophysiology of Haemostasis and Thrombosis 33(Suppl 1): 96

Nguyen, N.T.; Kassis, J. 2003: Thrombotic and infectious complications related to central venous catheters in patients with or without cancer. Blood 102(11): 112b-113b

Dereure, O.; Bessis, D.; Lavabre-Bertrand, T.; Exbrayat, C.; Fegueux, N.; Biron, C.; Guilhou, J.J. 2000: Thrombotic and necrotizing panniculitis associated with recombinant human granulocyte colony-stimulating factor treatment. British Journal of Dermatology 142(4): 834-836

Kelly, N.P.; Hoppensteadt, D.A.; Florian Kujawski, M.R.; Walenga, J.M.; Mayuga, M.; Fareed, J. 2003: Thrombotic and vascular pathogenesis in end stage renal disease Role of fibrinolytic deficit. Modern Pathology 16(1): 54A

Gorog, Diana Adrienne 1999: Thrombotic and/or thrombolytic status analyser. Official Gazette of the United States Patent and Trademark Office Patents 1223(5)

Del Zoppo, G.J. 2001: Thrombotic cerebrovascular disease. Bachmann, F Author Handbook of Experimental Pharmacology Fibrinolytics and antifibrinolytics 387-421

Potenza, L.; Luppi, M.; Morselli, M.; Saviola, A.; Ferrari, A.; Riva, Gì.; Longo, G.; Marietta, M.; Torelli, G. 2004: Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making. Thrombosis and Haemostasis 91(4): 834-836

Wolf, H.H.; Dorligschaw, O.; Von Poblotzki, A.; Schmoll, H.J. 2000: Thrombotic complications due to pegylated asparaginase in patients with acute lymphoblastic leukemias. Onkologie 23(Sonderheft 7): 69

Giglia, T.M.; Bulas, D.I.; Sell, J.E.; Chamberlain, R.S.; Quivers, E.S.; Pearson, G.D.; Gumpper, K.F.; Midgley, F.M.; Martin, G.R.; Luban, N.L.C. 2001: Thrombotic complications in a pediatric cardiovascular surgery population A nine-year experience. Journal of the American College of Cardiology 37(2 Suppl A): 465A

Atamer, T.; Yenerel, M.N.; Yavuz, A.S.; Kucukkaya, R.; Besisik, S.; Aktan, M.; Keskin, H.; Nalcaci, M.; Sargin, D.; Pekcelen, Y.; Dincol, G. 2001: Thrombotic complications in essential thrombocythemia. Blood 98(11 Part 2): 277b-278b

Goerttler, P.; Doerner, E.; Johansson, P.L.; Andreasson, B.; Kutti, J.; Moliterno, A.R.; Marchioli, R.; Spivak, J.L.; Pahl, H.L. 2003: Thrombotic complications in four subpopulations of patients with ET defined by c-Mpl protein expression and PRV-1 mRNA levels. Blood 102(11): 918a

Papa, A.; De Stefano, V.; Danese, S.; Gasbarrini, A.; Gasbarrini, G. 2001: Thrombotic complications in inflammatory bowel disease: a multifactorial etiology. American Journal of Gastroenterology 96(4): 1301-1302

Abdulkarim, A.; Kim, W.R.; Poterucha, J.J.; Rosen, C.B.; Wiesner, R.H. 2000: Thrombotic complications in liver transplant recipients for Budd-Chiari syndrome. Gastroenterology 118(4 Suppl 2 Pt 1): AASLD A970

Khan, S.; Kessler, S.; Peterson, S.J. 1999: Thrombotic complications of an HIV patient with antiphospholipid antibodies. JGIM 14(Suppl 2): 184

Diez Porres, L.; Gil Aguado, A.; Lavilla, P.; Pascual, D.; Cuesta, M.V.; Bernardino, J.I.; Mora, M.; Cobo, T.; Gaya, F. 2002: Thrombotic events in patients with APS, SLE and related diseases. Lupus 11(9): 596

Alves, J.; Inanc, M.; Diz Kucukkaya, R.; Soromenho, F.; Isenberg, D.A. 2001: Thrombotic events post-splenectomy in patients with SLE and antiphospholipid syndrome. Lupus 10(Suppl 1): S103

Papatheodoridis, G.V.; Papakonstantinou, E.; Andrioti, E.; Cholongitas, E.; Petraki, K.; Kontopoulou, I.; Hadziyannis, S.J. 2001: Thrombotic factors and extent of liver fibrosis in chronic viral hepatitis. Hepatology 34(4 Pt 2): 487A

Zareba, W.; Moss, A.J.; Marder, V.J.; Natarajan, S.; Weiss, H.J.; Miller Watelet, L.F. 1999: Thrombotic factors and left ventricular ejection fraction in postinfarction patients. European Heart Journal 20(ABSTR Suppl ): 120

Bucciarelli, S.; Espinosa, G.; Cervera, R.; Font, J.; Asherson, R.A.; Ingelmo, M. 2002: Thrombotic microangiopathic haemolytic anemia in APS. Lupus 11(9): 618

Chander, P.N.; Delaney, V.; Butt, K. 2001: Thrombotic microangiopathic lesions in grafts from donors 5 years of age to adult recipients. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 927A

Ruggenenti, P.; Aros, C.; Remuzzi, G. 2001: Thrombotic microangiopathies in the intensive care unit: many questions, some answers. Contributions to Nephrology 2001(132): 53-67

Miller, B.W.; Schnitzler, M.A.; Brennan, D.C. 2001: Thrombotic microangiopathy and CMV infection after renal transplantation. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 940A

Galicier, L.; Boulanger, E.; Francois, B.; Fieux, F.; Scrobohaci, M.L.; Clauvel, J.P. 2000: Thrombotic microangiopathy and antiphospholipid syndrome in multicentric Castlemans disease. Journal of Autoimmunity 15(2): A50

Houser, S.L.; Kuwaki, K.; Knosalla, C.; Dor, F.J.M.F.; Gollackner, B.; Cheng, J.; Schuurman, H.J.; Cooper, D.K.C. 2003: Thrombotic microangiopathy and necrosis in pig-to-baboon cardiac xenografts. Xenotransplantation 10(5): 481

Mor, E.; Lustig, S.; Tovar, A.; Bar-Nathan, N.; Shharabani, E.; Shapira, Z.; Yusim, A. 2000: Thrombotic microangiopathy early after kidney transplantation: hemolytic uremic syndrome or vascular rejection?. Transplantation Proceedings 32(4): 686-687

Shimoni, A.; Yeshurun, M.; Hardan, I.; Avigdor, A.; Papatryphonos, A.; Tsolakis, F.I.; Nagler, A. 2003: Thrombotic microangiopathy following allogeneic stem-cell transplantation in the era of reduced-intensity conditioning The incidence is not reduced. Blood 102(11): 466a

Pham, P-Thu.T.; Pham, P-Chi.T.; Wilkinson, A.H. 2003: Thrombotic microangiopathy following organ transplantation. Kidney International 63(5): 1959; Author Reply 1959-60

Bong, J.J.; Ammori, B.J.; McMahon, M.J.; Kumar, A.; Turney, J.H.; Norfolk, D.R. 2002: Thrombotic microangiopathy in acute pancreatitis. Pancreas 25(1): 107-109

Alpers, C.E.; Nicosia, R.F.; Smith, K.D.; Sustento Reodica, N.; Bensinger, W. 2002: Thrombotic microangiopathy in patients with multiple myeloma receiving peripheral blood stem cell transplant with holmium preconditioning. Laboratory Investigation 82(1): 276A

Klenzak, J.S.; Falk, R.J.; Jennette, J.C. 2000: Thrombotic microangiopathy in the absence of schistocytosis. Laboratory Investigation 80(3): 176A

Abraham, K.; Wong, C.; O'connell, F.; Dorman, A.; Walshe, J. 2002: Thrombotic microangiopathy in transplantation; changing incidence with newer calcineurin inhibitors. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 324

Van Schaardenburgh, P.; Steenvoorde, P.; de Bruïne, J.F.; Viersma, J.H.; Warmenhoven, P.G. 2003: Thrombotic resolution of a traumatic pseudoaneurysm of the anterior tibial artery after external compression. Journal of Trauma 55(3): 561-565

Papatheodoridis, G.; Papakonstantinou, E.; Andrioti, E.; Cholongitas, E.; Petraki, K.; Kontopoulou, I.; Hadziyannis, S. 2002: Thrombotic risk factors and extent of liver fibrosis in patients with chronic viral hepatitis. Journal of Hepatology 36(Suppl 1): 175

Schuehlen, H.; Pache, J.; Hausleiter, J.; Mehilli, J.; Dirschinger, J.; Kastrati, A.; Schoemig, A. 2000: Thrombotic stent occlusion and associated major adverse cardiac events beyond the first 2 weeks after coronary stent placement Analysis of 3676 patients with a 4-week ticlopidine regimen. Journal of the American College of Cardiology 35(2 Suppl A): 66A-67A

Cines, D.B.; Konkle, B.A.; Furlan, M. 2000: Thrombotic thrombocytopenic purpura: a paradigm shift?. Thrombosis and Haemostasis 84(4): 528-535

Pekcelen, Y.; Atamer, T.; Nalcaci, M.; Yavuz, S.; Diz Kucukkaya, R.; Aktan, M.; Yenerel, M.N.; Sargin, D.; Keskin, H. 2002: Thrombotic thrombocytopenic purpura Long-term results of splenectomy. Vox Sanguinis 83(Suppl 2): 100-101

Lankford, K.V.; Hillyer, C.D. 2000: Thrombotic thrombocytopenic purpura: new insights in disease pathogenesis and therapy. Transfusion Medicine Reviews 14(3): 244-257

Cazzola, M. 2000: HFE, iron homeostasis and genetic hemochromatosis. Haematologica 85(4): 338-339

Sobecks, R.; Rybicki, L.; Kalaycio, M.; Andresen, S.; Pohlman, B.; Lichtin, A.; West, A.; Sands, K.; Kosar, J.; Serafin, M.; Foster, L.; Berry, N.; Mc 2003: Thrombotic thrombocytopenic purpura after allogeneic hematopoietic stem cell transplantation. Blood 102(11): 434b

Kelton, J.G. 2002: Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: will recent insight into pathogenesis translate into better treatment?. Transfusion 42(4): 388-392

Hosler, G.A.; Cusumano, A.M.; Hutchins, G.M. 2002: Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities A review of 56 autopsied patients. Laboratory Investigation 82(1): 5A

Durand, J.M.; Gautier, C.; Salas, S.; Retornaz, F.; Lefevre, P. 1999: Thrombotic thrombocytopenic purpura and hypothyroidism. American Journal of Hematology 61(1): 83-84

Baker, K.R.; Moake, J.L. 2000: Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Current Opinion in Pediatrics 12(1): 23-28

Korin, J.; Ferro, H.; Barazzutti, L.; Tartas, N.; Roel, J.; Lantos, J.; Grassi, D.; Sanchez Avalos, J. 2000: Thrombotic thrombocytopenic purpura as a first manifestation of systemic lupus erythematosus. Haemostasis 30(Suppl 1): 91-92

Riegert-Johnson, D.L.; Sandhu, N.; Rajkumar, S.V.; Patel, R. 2002: Thrombotic thrombocytopenic purpura associated with a hepatic abscess due to Actinomyces turicensis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 35(5): 636-637

Yoneda, S.; Yoshikawa, M.; Kobayashi, Y.; Yamane, Y.; Nakatani, T.; Iwasawa, S.; Nishimura, K.; Watanabe, I.; Sakaguchi, T.; Kojima, Y.; Nakano, H.; Fukui, H. 1999: Thrombotic thrombocytopenic purpura associated with advanced gastric cancer. Nihon Shokakibyo Gakkai Zasshi 96(8): 947-952

Donato, M.L.; Korbling, M.J.; Anderlini, P.; Lichtiger, B.; Martin, T.G.IIi; Champlin, R.E. 2000: Thrombotic thrombocytopenic purpura following allogeneic transplantation High incidence of infectious cause and high rate of resolution with total plasma exchange. Blood 96(11 Part 1): 630a-631a

Trevenzoli, M.; Cattelan, A.; Lanzafame, M.; Parisi, S.; Concia, E. 1999: Thrombotic thrombocytopenic purpura in HIV patients. Giornale Italiano di Malattie Infettive 5(4): 252-253

Alexopoulou, A.; Dourakis, S.P.; Kaloterakis, A. 2002: Thrombotic thrombocytopenic purpura in a patient treated with clarithromycin. European Journal of Haematology 69(3): 191-192

Ringelmann, F.; Gruhn, B.; Kentouche, K.; Patzer, L.; Roennefarth, G.; Misselwitz, J. 1999: Thrombotic thrombocytopenic purpura in an adolescent with congenital chronic relapsing microangiopathic anemia and thrombocytopenia. Pediatric Nephrology 13(7): C42

Cummins, D.; Jenkins, G.; Hall, A.; Banner, N.; Burke, M. 1999: Thrombotic thrombocytopenic purpura in association with acute toxoplasmosis after cardiac transplantation. British Journal of Haematology 105(Suppl 1): 40

Porta, C.; Bobbio Pallavicini, E.; Piovella, F.; Natalizi, A.; Ferrari, S.; Libre, L.; Danova, M. 2001: Thrombotic thrombocytopenic purpura in cancer patients receiving chemotherapy Evidence of increased nitric oxide production. Haemostasis 31(Suppl 1): 95

Tukic, L.; Stamatovic, D.; Tarabar, O.; Karajovic, J.; Stefanovic, D.; Malesevic, M. 2000: Thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Fibrinolysis and Proteolysis 14(Suppl 1): 86

Mccarthy, L.J.; Skipworth, E.; Vieira, M.; Houck, W.; Danielson, C.F.M.; Waxman, D. 2002: Thrombotic thrombocytopenic purpura induced by Cisplatin. Vox Sanguinis 83(Suppl 2): 100

Takei, H.; Kao, Y.; Eicher, C.A. 1999: Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in patients with HIV infection A report of four cases. Transfusion 39(10 Suppl): 8S

Lowe, G.; Woodward, M.; Vessey, M.; Rumley, A.; Gough, P.; Daly, E. 1999: Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years Relationships to hormone replacement therapy. Blood Coagulation and Fibrinolysis 10(8): 530

Starck, M.; Fohr, K.; Fischer, N.; Abedinpour, F.; Nerl, C. 2000: Thrombotic-thrombocytopenic purpura associated with malignoma Four cases with fatal outcome. Onkologie 23(Sonderheft 7): 181

Nawa, H.; Kurosaki, Y.; Kawasaki, H. 2002: ThromboxanA2 and prostaglandin H2 mediate bradykinin-induced vasoconstriction in rat mesenteric resistance arteries. Japanese Journal of Pharmacology 88(Suppl 1): 269P

Dzgoeva, F.; Kutyrina, I.; Salbiev, K.; Dzgoeva, Z. 1999: Thromboxane A2 and prostacyclin in contrast media nephrotoxicity Protective effects of calcium antagonists. Nephrology Dialysis Transplantation 14(9): A73

Kawada, N.; Dennehy, K.; Moriyama, T.; Imai, E.; Welch, W.J.; Wilcox, C.S. 2003: Thromboxane A2 and thromboxane A2-prostaglandin H2 receptors regulate renal hemodynamics during angiotensin II slow pressor response. Journal of the American Society of Nephrology 14(Abstracts Issue): 611A

Ashton, A.W.; Ryoji, Y.; John, G.; Suadicani, S.O.; Spray, D.C.; Ware, J.A.thony 1999: Thromboxane A2 antagonizes the pro-angiogenic effects of fibroblast growth factor-2 by preventing receptor internalization. Circulation 100(18): 1; 39

Phan, A.C.; Fu, L.W.; Longhurst, J.C. 2002: Thromboxane A2 contributes to cardiac-cardiovascular pressor reflexes during myocardial ischemia. FASEB Journal 16(5): A833

Orea, V.; Benzoni, D.; Sassard, J. 2000: Thromboxane A2 does not potentiate the renal vasoconstrictor effect of angiotensin II. Fundamental and Clinical Pharmacology 14(3): 278

Wacker, M.J.; Tehrani, R.N.; Orr, J.A. 1999: Thromboxane A2 elicits a vagally-mediated cardiovascular reflex from the heart. FASEB Journal 13(4 Part 1): A445

Yusuf, K.; Smith, S.D.; Sadovsky, Y.; Nelson, D.M.chael 2001: Thromboxane A2 induced apoptosis of cultured human trophoblasts Role of poly polymerase. Pediatric Research 49(4 Part 2): 54A

Daniel, T.O.; Liu, H.; Morrow, J.D.; Crews, B.C.; Marnett, L.J. 1999: Thromboxane A2 is a mediator of COX-2 dependent endothelial migration and angiogenesis. Prostaglandins and Other Lipid Mediators 59(1-6): 65

Lacza, Z.; Kaldi, K.; Koevecs, K.; Goerlach, C.; Nagy, Z.; Sandor, P.; Benyo, Z.; Wahl, M. 2000: Thromboxane A2 mediates the cerebrovascular contractile effect of uridine-5-triphosphate. Journal of Physiology (Cambridge) 526P: 141P-142P

Murakami, Y.; Yokotani, K.; Okada, S.; Osumi, Y. 1999: Thromboxane A2 mimetics activate central adrenomedullary outflow in rats. Japanese Journal of Pharmacology 79(Suppl 1): 233P

Koba, S.; Watanabe, T.; Katagiri, T.; Pakala, R.; Benedict, C.R. 2000: Thromboxane A2 potentiates mitogenic effect of mildly oxidized low density lipoproteins on vascular smooth muscle cells. Journal of the American College of Cardiology 35(2 Suppl A): 269A

Thomas, D.W.; Nataraj, C.; Robinson, L.A.; Bautch, V.L.; Coffman, T.M. 1999: Thromboxane A2 promotes adhesion of leukocytes to endothelial cells. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 539A

Patan, S.; Nomura, M.; Coffman, T.M.; Ware, J.A.thony 2002: Thromboxane A2 receptor deficiency promotes angiogenesis after myocardial infarction in transgenic mice. Circulation 106(19): II267

Sasaki, M.; Miyosawa, K.; Sukegawa, J.; Yanagisawa, T.; Ohkubo, S.; Nakahata, N. 2004: Thromboxane A2 receptor isoforms are differently regulated by proteasome. Journal of Pharmacological Sciences 94(Suppl 1): 98P

Tyburski, J.B.; Koster, C.J.; Lundquist, E.A.; Floor, E.; Wu, J.Y.; Orr, J.A. 2002: Thromboxane A2 receptor mRNA expression in rat sensory ganglia neurons. FASEB Journal 16(5): A832

Kobayashi, H.; Honma, S.; Nakahata, N.; Ohizumi, Y. 1999: Thromboxane A2 receptor-mediated activation of mitogen activated protein kinase is not involved in Gq-PI-PLC in human astrocytoma cells. Japanese Journal of Pharmacology 79(Suppl 1): 130P

Yamada, T.; Fujino, T.; Yuhki, K.I.; Hara, A.; Narumiya, S.; Ushikubi, F. 2003: Thromboxane A2 regulates vascular tone via the inhibitory effect on the expression of inducible nitric oxide synthase. Journal of Pharmacological Sciences 91(Suppl I): 76P

Nie, D.; Lamberti, M.; Szekeres, K.; Tang, K.; Zacharek, A.; Li, L.; Chen, Y.; Honn, K.V. 2000: Thromboxane A2 regulation of angiogenesis. Proceedings of the American Association for Cancer Research Annual Meeting 41: 793

Nie, D.; Szekeres, K.; Tang, K.; Zacharek, A.; Li, L.; Chen, Y.; Honn, K.V. 1999: Thromboxane A2 regulation of angiogenesis and tumor metastasis. Prostaglandins and Other Lipid Mediators 59(1-6): 138

Lombard, J.H.; Sylvester, F.A.; Phillips, S.A.; Frisbee, J.C. 2002: Thromboxane A2 release and impaired G-protein coupling contribute to loss of hypoxic dilation in middle cerebral arteries of rats on a high salt diet. FASEB Journal 16(4): A78-A79

Xu, H.; Korneszczuk, K.; Clemens, M.G.; Zhang, J.X. 2003: Thromboxane A2 released from Kupffer cells is responsible for the hyper-responsiveness of hepatic portal circulation to endothelin-1 in endotoxemic rats. Hepatology 38(4 Suppl 1): 250A

Ashton, A.W.; Ware, J.A. 2001: Thromboxane A2 signaling inhibits VEGF-induced endothelial cell proliferation and migration. Circulation 104(17): 2; 35

Kinsella, B.T. 2001: Thromboxane A2 signalling in humans: a 'Tail' of two receptors. Biochemical Society Transactions 29(Part 6): 641-654

Fu, L.W.; Longhurst, J.C. 2002: Thromboxane A2 stimulates ischemically sensitive cardiac afferents. FASEB Journal 16(5): A830

Cao, W.; Harnett, K.M.; Behar, J.; Biancani, P. 2000: Thromboxane A2-induced contraction of cat esophageal and lower esophageal sphincter circular smooth muscle. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1102

Pudar, G.; Janosevic, S.; Brankovic, A. 2000: Thromboxane biosynthesis in diabetics. Diabetologia 43(Suppl 1): A270

Beauchamp, M.; Speranza, G.; Hou, X.; Najarian, T.; Varma, D.R.; Chemtob, S. 2000: Thromboxane induces endothelial death and is involved in neurovascular degeneration. Pediatric Research 47(4 Part 2): 389A

Beauchamp, M.; Speranza, G.; Hou, X.; Lachapelle, P.; Roberts, J.II.V.rma, D.R.; Chemtob, S. 2000: Thromboxane induces endothelial death and is involved in vascular degeneration. Journal of Investigative Medicine 48(2): 183A

Nanji, A.A.; Jokelainen, K.; Khwaja, S.; Rahemtulla, A.; Lalani, E.N.sir 2000: Thromboxane inhibitors reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. Hepatology 32(4 Pt 2): 387A

Burk, R.M.; Krauss, A.H.; Woodward, D.F. 2000: Thromboxane ligands. Official Gazette of the United States Patent and Trademark Office Patents 1236(3)

Burk, R.M.; Krauss, A.H.P.; Woodward, D.F. 2002: Thromboxane ligands without blood clotting side effects. Official Gazette of the United States Patent and Trademark Office Patents 1263(2)

Henriksen, R.A.; Hanks, V.K. 2001: Thromboxane production in response to protease activated receptor-4 agonist peptide AYPGKF-NH2. Blood 98(11 Part 1): 243a-244a

Kawada, N.; Karber, A.; Imai, E.; Welch, W.J.; Wilcox, C.S. 2003: Thromboxane receptors regulate blood pressure and renal hemodynamics during the angiotensin II slow pressor response. FASEB Journal 17(4-5): Abstract

Wang, L.-H.; Kulmacz, R.J. 2002: Thromboxane synthase: structure and function of protein and gene. Prostaglandins and other Lipid Mediators 68-69: 409-422

Wilcox, C.S.; Welch, W.J. 2002: Thromboxane synthase and TP receptor mRNA in rat kidney and brain Effects of salt intake and Ang II. Circulation 106(19): II234

Fike, C.D.; Kaplowitz, M.R. 2003: Thromboxane synthase inhibitor/receptor antagonist treatment ameliorates chronic hypoxia-induced pulmonary hypertension in newborn piglets. FASEB Journal 17(4-5): Abstract 308

Graupera, M.; Garcia Pagan, J.C.; Fernandez, M.; Bosch, J.; Rodes, J. 2002: Thromboxane-A2 overproduction via de COX-1 pathway is involved in the hyperesponse to Methoxamine of cirrhotic rat livers. Hepatology 36(4 Part 2): 176A

Gallet, C.; Blaie, S.ép.; Lévy-Toledano, S.; Habib, A.ïd. 2003: Thromboxane-induced ERK phosphorylation in human aortic smooth muscle cells. Advances in Experimental Medicine and Biology 525: 71-73

Aktas, B.; Hoenig Liedl, P.; Walter, U.; Geiger, J. 2001: Thromboxane-induced serotonine secretion is potentiated via Gi-coupled receptors in human platelets. Naunyn-Schmiedeberg's Archives of Pharmacology 363(4): R8

Qiu, X.; Mcneill, J.R.; Ghosh, M. 2004: Thromboxane/prostaglandin receptor antagonist, SQ 29548, blocks 20-hydroxyeicosatetraenoic acid induced increases of spontaneous tone in aorta of deoxycorticosterone acetate -salt hypertensive rats. FASEB Journal 18(4-5): Abstract 641

Kano, T. 1999: Thrombozed giant aneurysm at the top of the basilar artery. Nichidai Igaku Zasshi 58(10): 477-479

D.L., D.; Cioffi, M.; Schiavone, E.M.; Pignalosa, O.; Carannante, S.; Petrosino, G.; Francesco, F.D.; Fratta, M.; Quarantiello, M.; Paternosto, D.; Terracciano, A.M.; Giudice, V.D.; Sica, V.; Molinari, A.M. 2002: Thrombus Precursor Protein, FXIIa and Antiphospholipid Antibodies as Markers of Early Thrombosis in Ischemic Disorders. Blood 100(11): Abstract No. 3867

Vachon, D.J. 1999: Thrombus and tissue ingrowth inhibiting overlays for defibrillator shocking coil electrodes. Official Gazette of the United States Patent and Trademark Office Patents 1218(3): 2105

Sheiban, I.; Moretti, C.; Prathap, K.; Sciuto, F.; Gagnor, A.; Omede, P.; Truffa, A.; Marra, W.G.; Shoheib, A.; Lucciola, M.T.; Trevi, G. 2004: Thrombus aspiration for the treatment of no-reflow phenomenon complicating primary angioplasty for acute myocardial infarction. Journal of the American College of Cardiology 43(5 Suppl A): 248A

Gaul, C.; Heckmann, J.G.; Bremer, J.; Wasmeier, G.; Huk, W.J.; Schraeder, R.; Neundoerfer, B.; Nixdorff, U. 2004: Thrombus attached to a Sideris septal occluder device after 6 years. DMW Deutsche Medizinische Wochenschrift 129(3): 87-90, 16 Januar

Dries, A.M.; Greenberg, R.K.; Ouriel, K.; Srivastava, S.D. 1999: Thrombus characterization with intravascular ultrasound The potential to predict successful thrombolysis. Circulation 100(18): 1; 101

Asano, K.; Ito, H.; Kawano, S.; Iwakura, K.; Katoh, A.; Ikushima, M.; Tanaka, K.; Inoue, Y.; Kuroda, T.; Okamura, A.; Fujii, K. 2002: Thrombus embolization as a cause of acute myocardial infarction Its frequency and implication of treatment. Journal of the American College of Cardiology 39(5 Suppl A): 285A

Gharavi, A.E.; Pierangeli, S.S.; Espinola, R.G.; Liu, X.; Harris, E.N.gel 2000: Thrombus enhancement and endothelial cell activation in vivo by CMV peptide-induced antiphospholipid antibodies. Journal of Autoimmunity 15(2): A91

Dimatteo, K. 2001: Thrombus filter with break-away anchor members. Official Gazette of the United States Patent and Trademark Office Patents 1245(3)

Kaibara, M.; Iwata, H. 1999: Thrombus formation by direct activation of factor IX on erythrocyte membrane at stasis From rheological studies to biochemistry. Biorheology 36(1-2): 124

Ishii, H.; Yoshida, M.; Hajjar, K.A.; Tanaka, A.; Yasukochi, Y.; Numano, F. 2001: Thrombus formation in rat carotid artery was inhibited by administration of recombinant annexin II. Circulation 104(17): 2; 126

Rosen, E.D.; Noria, F.; Roahrig, J.; Zollman, A.; Castellino, F.J. 2003: Thrombus formation in response to laser-induced vascular injury in fibrinogen deficient mice. Blood 102(11): 792a-793a

Marshall, S.J.; Senis, Y.A.; Auger, J.M.; Salmon, G.; Watson, S.P. 2003: Thrombus formation is mediated through a SRC kinase-dependent pathway but does not require activation of mapkinase or cGMP-dependent kinases. Blood 102(11): 291a

Sievert, H.; Krumsdorf, U.; Horvath, K.; Ostermayer, S.; Billinger, K.; Thomas, T. 2003: Thrombus formation on atrial septal defect and patent foramen ovale closure devices Incidence and clinical outcome in 1,000 consecutive patients. Journal of the American College of Cardiology 41(6 Suppl A): 473A

Sanchez Gomez, S.; Alfon, J.; Badimon, L. 2000: Thrombus growth on residual thrombus is inhibited and vascular wall Cox2 upregulated by treatment with triflusal. European Heart Journal 21(Abstract Suppl): 79

Dean, R.T.; Lister James, J. 2000: Thrombus imaging agents. Official Gazette of the United States Patent and Trademark Office Patents 1236(1)

Jin, J.; Wan, W.X.; Zhang, R.J.; Zhou, Y.; Tan, C.; Tao, Y.H.; Cai, G.M.; Zhang, L.F. 1999: Thrombus imaging potency of recombinant hirudin in vitro by thrombin targeting. Journal of Labelled Compounds and Radiopharmaceuticals 42(Suppl 1): S809-S811

Bowers, M.J.; Jones, F.G.C. 2002: Thrombus in harvested marrow from a patient with recent heparin-induced thrombocytopenia. British Journal of Haematology 119(2): 294

De Godoy, J.é M.P.; de Marchi, C.H.; Silva, M.G.ça.F.; Carvalho, M.C.M.; Moscardini, A.; Tonet, T. 2002: Thrombus in the left ventricle of a newborn. Journal of Pediatrics 141(1): 141

Lee, J.A. 1999: Thrombus macerator catheter. Official Gazette of the United States Patent and Trademark Office Patents 1226(3)

Lacour, J-C.; Ducrocq, X.; Moret, C.; Anxionnat, R.; Richard, S.; Bracard, S.; Barroche, G. 2003: Thrombus of the left lateral sinus spreading to the internal jugular vein. Revue Neurologique (Paris) 159(4): 451-454

Arkel, Y.S.; Bodner, R.; Ku, D.H.; Lake, C.; Siciliano, F.; Lam, X. 1999: Thrombus precursor protein as a measure of prothrombotic activity in a patient with factor VIIi inhibitor treated with activated prothrombin complex concentrates. Thrombosis and Haemostasis 82(1): 152-153

De Lucia, D.; Maisto, G.; Del Giudice, V.; De Francesco, F.; Quarantiello, M.; Papa, M.; Toso, V.II 2001: Thrombus precursor protein as a new marker of thrombophilia in stroke. European Journal of Neurology 8(Suppl 2): 19

Bode, C.; Peter, K.; Runge, M.S.; Haber, E. 2001: Thrombus-targeting of plasminogen activators. Bachmann, F Author Handbook of Experimental Pharmacology Fibrinolytics and antifibrinolytics 473-492

Bogdanovich, R.N.; Chikalovets, I.V.; Berestovaya, T.A. 2004: Throphoblastic beta1-glycoprotein in clinical practice. Klinicheskaya Laboratornaya Diagnostika 2: 3-8

Mcilwain, I.D. 1999: Throttle control for baler engine. Official Gazette of the United States Patent and Trademark Office Patents 1221(4)

Na, X.; Schoen, S.R.; Wu, G.; Messing, E.M. 2002: Through Cathepsin B, VHL mutations promote renal tumor cell invasion in metastases. Proceedings of the American Association for Cancer Research Annual Meeting 43: 146-147

Rosai, J. 2003: Through a glass darkly Lessons from the GIST saga. Journal of Pathology 201(Suppl): 59A

Singh, J.; Yoon, G.; Singh, D.; Soneji, S.; Lantos, J.; Meadow, W. 2000: Through a glass darkly? Predictive value of indices of non-survival for ultra-low-birthweight infants in the first hours of life. Pediatric Research 47(4 Part 2): 432A

Tyler, K.L.; McArthur, J.C. 2002: Through a glass, darkly: cerebrospinal fluid viral load measurements and the pathogenesis of human immunodeficiency virus infection of the central nervous system. Archives of Neurology 59(6): 909-912

Mcholm, D.C. 2004: Through assessment design and active engagement of students, plagiarism can be minimized in large undergraduate physiology classes. FASEB Journal 18(4-5): Abstract 299

Burgess, K.; Gibbs, R. 2002: Through bond energy transfer in fluorescent dyes for labelling biological molecules. Official Gazette of the United States Patent and Trademark Office Patents 1254(4)

Lewis, D.; Branbilla, G.; Ganderton, D.; Howlett, D.; Meakin, B.J. 1999: Through can life variation in delivered dose from pMDIs. Journal of Pharmacy and Pharmacology 51(Suppl ): 181

Gottlieb 1999: Thorough cancer surgery may make radiation unnecessary. BMJ 318(7195): 1369

Rozenberg, G. 2000: Through the eyes of the microscope. Australian Journal of Medical Science 21(4): 4-14

Sivak, J.G.; Sivak, J.G. 2004: Through the lens clearly: phylogeny and development: the Proctor lecture. Investigative Ophthalmology and Visual Science 45(3): 740-7; 739

Gosden, R.G. 2000: Through the looking glass Speculations of the future of female reproductive biology. Biology of Reproduction 62(Suppl 1): 79-80

Kollbaum, P.; Begley, C.; Bradley, A. 2001: Through-focus contrast sensitivity in presbyopic contact lens corrections. IOVS Investigative Ophthalmology and Visual Science 42(4): S593

Butterfield, D. 1999: Through-package applications of Raman spectroscopy for nondestructive identification of product. American Laboratory 31(23): 14

Castaneda, Javier E.; Francese, Jose Luis; Palmer, Matthew A.; De La Torre, Ralph 2003: Through-port heart stabilization system. Official Gazette of the United States Patent and Trademark Office Patents 1272(3)

Matsushita, M.; Takakuwa, H.; Matsubayashi, Y.; Oshima, C.; Maeda, H.; Kido, M.; Arakawa, H. 2004: Through-the-endoscope technique for retrieval of impacted biliary baskets with trapped stones. American Journal of Gastroenterology 99(6): 1198-1199

Luther, R.B.; Elson, E.E. 1999: Through-the-needle cannula and split needle placement apparatus and method of use. Official Gazette of the United States Patent and Trademark Office Patents 1227(4)

Bouquot, J.E.; Shankland, W.E.; Margolis, M.; Glaros, W. 2002: Through-transmission alveolar ultrasonography New technology for detection of low bone density of the jaws Comparison with radiology for 92 osteoporotic alveolar sites with histopathologic confirmation. Journal of Oral Pathology and Medicine 31(5): 289-290

Clarke, G.; O'connor, G.M.; Sherlock, R.; O'driscoll, A.; Mcnamara, C.; Mcdonagh, H. 2004: Through-transmission welding of catheter components. Official Gazette of the United States Patent and Trademark Office Patents 1282(4)

Bellot, J.; Avila, A.; Rodrigo, A. 1999: Throughfall and stemflow. Roda, R, Retana, J, Gracia, C A, Bellot, J Ecological Studies; Ecology of Mediterranean evergreen oak forests 209-222

Luoma, R.P.; Coffee, E.E.; Arnquist, D.; Ball, D.J.; Ochranek, B.; Richey, P.; Smith, K. 2002: Throughput and workflow analysis of the Abbott ARCHITECT ci8200TM c8000TM and i2000 srTM. Clinical Chemistry 48(6 Suppl): A8-A9

Coers, B.A.; Teijido, J.A.; Burke, D.J.; Tsunemori, T.S.; Peterson, J.V.; Cooper, W.F.; Littke, J.D.; Kis, J. 2002: Throughput control for combines having a variable torque sensing drive. Official Gazette of the United States Patent and Trademark Office Patents 1264(1)

Davis, A.R.; Fish, W.W.; Perkins Veazie, P. 2002: Throw away the hexane A novel spectrophotometric method for analyzing lycopene content in watermelon, tomato, and grapefruit. HortScience 37(5): 742-743

Trueblood, Nathan Andrew 2003: Throw out the lab manual and let the student inquiry begin Student designed, semester long research projects model the activities of scientists and enrich the undergraduate physiology laboratory experience. FASEB Journal 17(4-5): Abstract 278

Dunsworth, H.; Challis, J.H. 2004: Throwing ability in fossil hominids. American Journal of Physical Anthropology Suppl (38): 90

Westergaard, G.C.; Cleveland, A.; Rocca, A.M.; Wendt, E.L.; Brown, M.J. 2003: Throwing behavior and the mass distribution of rock selection in tufted capuchin monkeys. American Journal of Physical Anthropology Suppl (36): 223

Curtis, A.S.; Deshmukh, R. 2003: Throwing injuries: diagnosis and treatment. Arthroscopy: the Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 19(Suppl 1): 80-85

Kalivoda, K.A.; Vimr, E.R. 2002: Throwing the switch How microbial pathogens make the metabolic decision to degrade, synthesize or scavenge sialic acids. Glycobiology 12(10): 699

Silversmith, R.E.; Bourret, R.B. 1999: Throwing the switch in bacterial chemotaxis. Trends in Microbiology 7(1): 16-22

Misiewicz, G.; Lebsack, K.L.on 2003: Thrust collar for encasing natural casings, and method of use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1275(4)

Cipollari, P.; Cosentino, D.; Esu, D.; Girotti, O.; Gliozzi, E.; Praturlon, A. 1999: Thrust-top lacustrine-lagoonal basin development in accretionary wedges Late Messinian episode in the central Apennines. Palaeogeography Palaeoclimatology Palaeoecology 151(1-3): 149-166

Pack, J. 2001: Thrusting rod. Official Gazette of the United States Patent and Trademark Office Patents 1247(4)

Ochyra, R.; Smith, V.R.; Gremmen, N.J.M. 2003: Thuidium delicatulum Schimp Another bipolar moss disjunct from Subantarctic Marion Island. Cryptogamie Bryologie 24(3): 253-263

Colditz, J.C. 2004: Thumb CMC restriction splint. Official Gazette of the United States Patent and Trademark Office Patents 1280(2)

Vucetic, C.; Djurdjevic, A.; Jankovic, S.; Karovic, B. 2000: Thumb motion following replantation. Microsurgery 20(6): 293

Baxter, C.O.; Harper, R.M. 2004: Thumb pad actuator for an ultrasonic surgical instrument. Official Gazette of the United States Patent and Trademark Office Patents 1281(2)

Swanbeck, T.L. 2003: Thumb protector and method therefor. Official Gazette of the United States Patent and Trademark Office Patents 1268(3)

Fisher, H. 2004: Thumb splint. Official Gazette of the United States Patent and Trademark Office Patents 1285(5)

Slautterback, E.G. 2000: Thumb wrist splint and method. Official Gazette of the United States Patent and Trademark Office Patents 1240(2)

Stansbury, L.Dean 2002: Thumb-powered flushing device for catheters. Official Gazette of the United States Patent and Trademark Office Patents 1265(5)

Stawate, T.; Lazaz, A.; Budvica, A.R. 2000: Thumbs distal phalaux reconstruction Replantation, toe to hand transfer or modified Mantero-Bertolotti?. Microsurgery 20(6): 307

Konstantinidis, P.; Gemballa, S.; Donley, J.M.; Shadwick, R.E. 2004: Thunniform swimmers with internalized red muscles Derived features in the musculotendinous system of Mako sharks. Journal of Morphology 260(3): 304-305

Frischbier,N.; Profft,I.; Arenhovel,W. 2010: Thuringian tree species recommendations for adaptation to climate change. Forst Und Holz: 2, 28-35

Brockhoff,P.B.; Christensen,R.H.B. 2010: Thurstonian models for sensory discrimination tests as generalized linear models. Food Quality And Preference: 3, 330-338

Mesaric, M.; Jandric, Z. 2000: Thus sphingoid long-chain bases research started. Periodicum Biologorum 102(4): 441-446

Devadas, S.; Shi, Y.F.ng 2002: Thx cells A new subset in T helper cells, are they born to die. Cell Research 12(3-4): 301

Li, R.; Bourne, P.; Ma, Z.W. 2003: Thy-1 protein, a potential tumor marker, identified in various tumor cells with nuclear localization. Modern Pathology 16(1): 297A

Kawamoto, K.; Morishige, N.; Nishida, T. 2004: Thygesons superficial punctate keratitis. Rinsho Ganka 58(7): 1136-1138

Herrmann, R.G. 2001: Thylakoid biogenesis and dynamics The result of a complex phylogenetic puzzle. Aro, Eva-Mari , Reprint Author, Andersson, Bertil Regulation of photosynthesis: 1-28

Sarcina, M.; Murata, N.; Mullineaux, C.W. 2001: Thylakoid membrane fluidity and its crucial importance in photoinhibition. Photosynthesis Research 69(1-3): 82

Herrmann, R.G. 1999: Thylakoid membranes in chloroplasts Biogenetic and phylogenetic complexity. Journal of Experimental Botany 50(Suppl ): 47

Tikkanen, M.; Grieco, M.; Kangasjärvi, S.; Aro, E.-M. 2010: Thylakoid protein phosphorylation in higher plant chloroplasts optimizes electron transfer under fluctuating light. Plant Physiology 152(2): 723-735

Sinibaldi Vallebona, P.; Pierimarchi, P.; Moroni, G.; Serafino, A.; Fuggetta, M.P.; Tuthill, C.; Rasi, G. 2002: Thymalfasin up-regulates tumor antigen expression in colorectal cancer cells. Tumor Biology 23(Suppl 1): 45

Stewart, J.C.; Mckenna, M.A. 2001: Thyme seedlings and thyme essential oil enhance nodulation and shoot weight of white clover. Ecological Society of America Annual Meeting Abstracts 86: 349

Romi, F.; Gilhus, N.E.; Varhaug, J.E.; Myking, A.; Skeie, G.O.; Aarli, J.A. 2003: Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis. Annals of the new York Academy of Sciences 998: 481-490

Katariya, K.; Ruiz, J.; Thurer, R.J.; Bolooki, H. 2000: Thymectomy for myasthenia gravis A retrospective review. Chest 118(4 Suppl): 208S

Anlar, B.; Ozdirim, E. 1999: Thymectomy in children with myasthenia gravis. Neuropediatrics 30(1): 49

Shahrizaila, N.; Pacheco, O.A.; Vidal, D.G.; Miyares, F.R.; Wills, A.J. 2004: Thymectomy in myasthenia gravis Comparison of outcome in Santiago, Cuba and Nottingham. Journal of Neurology Neurosurgery and Psychiatry 75(8): 1214

Holmes, W.C.; Pruski, J.F.; Singhurst, J.R. 2000: Thymelaea passerina new to Texas. SIDA Contributions to Botany 19(2): 403-406

Beyers, J.B.P. 2002: Thymelaeaceae A new species of Gnidia from the Knersvlakte, Western Cape, South Africa. Bothalia 32(1): 79-81,

Bredenkamp, C.L.; Van Wyk, A.E. 2002: Thymelaeaceae Systematics of Passerina truncata and a new subspecies Monticola. Bothalia 32(1): 65-71,

Tackenberg, B.; Nitschke, M.; Willcox, N.; Ziegler, A.; Nessler, S.; Vanucchi, A.; Koester, H.; Moosdorf, R.; Oertel, W.; Hemmer, B.; Sommer, N. 2002: Thymic T cell repertoire diversity in adult and aged human individuals. FASEB Journal 16(4): A346

Terra, R.; Labrecque, N.; Perreault, C. 2002: Thymic and extra-thymic T cell developement pathways follow different rides. FASEB Journal 16(4): A341

Fändrich, F.; Lin, X.; Huang, D.S.; Zhu, X.; Parwaresch, R.; Kremer, B.; Henne-Bruns, D. 1999: Thymic and liver graft expression of CD95-L tolerizes allogeneic orthotopic liver grafts. Transplantation Proceedings 31(1-2): 438-439

Krenger, W.; Rossi, S.; Piali, L.; Hollander, G.A. 2000: Thymic atrophy in murine acute graft-versus-host disease is effected by increased apoptosis of CD4+CD8+ thymocytes and by impaired cell cycle progression of CD3-CD4-CD8- cells. FASEB Journal 14(6): A1073

Soda, G.; Bosco, D.; Nardoni, S.; Melis, M. 1999: Thymic basaloid carcinoma arisen from laterocervical thymic cyst Does it really exist?. Virchows Archiv 435(3): 337

Axelson, J.; Kobari, M.; Furukawa, T.; Matsuno, S. 1999: Thymic carcinoid in the pancreas: metastatic disease or new primary tumours. European Journal of Surgery 165(3): 270-273

Chalabreysse, L.; Gengler, C.; Tabib, A.; Loire, R.; Thivolet Bejui, F. 2001: Thymic carcinoma A series of twenty cases. Virchows Archiv 439(3): 344

Chen, H.H.W.; Chen, F.F.; Lai, W.W.; Su, W.C.; Wu, M.H.; Leung, H.W.C. 2002: Thymic carcinoma Outcome of radiotherapy with or without platinum-based chemotherapy. International Journal of Cancer Suppl (13): 454-455

Woenckhaus, C.; Von Suchodoletz, H.; Festge, O.A.; Lorenz, G. 2000: Thymic cyst An unusual lesion of the lateral neck. Pathology Research and Practice 196(6): 369

Zheng, X.T.; Gao, J.; Geiger, T.; Liu, Y.; Zheng, P. 2001: Thymic deletion of specific T cells reactive to SV40 large T antigen in TRAMP mice. FASEB Journal 15(4): A240

Hünig, T.; Torres-Nagel, N.; Mehling, B.; Park, H.J.; Herrmann, T. 2001: Thymic development and repertoire selection: the rat perspective. Immunological Reviews 184: 7-19

Bennuri, B.; Chavan, S.; Bakshi, S.; Kharbanda, M.; Pahwa, S. 2000: Thymic emigrant cells in peripheral blood of HIV infected children correlate with response to antiretroviral therapy. Journal of Allergy and Clinical Immunology 105(1 part 2): S265

Blazar, B.R.; Min, D.; Chung, B.; Panoskaltsis Mortari, A.; Farrell, C.; Lacey, D.; Taylor, P.A. 2001: Thymic epithelial cell injury is inhibited by pre-BMT keratinocyte growth factor A new approach to facilitate thymopoiesis in AlloBMT recipients. FASEB Journal 15(4): A666

Sands, S.S.; Rickords, L.F.; Hayashi, J.; Ketchum, R.J. 2001: Thymic epithelial cells induce specific tolerance upon intrathymic transplantation, and may be transduced with genes encoding novel proteins, resulting in novel gene expression. Cell Transplantation 10(6): 524

Mackenzie Graham, A.; Liu, H.; Voskuhl, R.R. 2000: Thymic expression of classic MBP is greater in mice less susceptible to EAE. FASEB Journal 14(6): A1120

Ponchel, F.; Morgan, A.; Douglas, S.; Bingham, S.; Emery, P.; Isaacs, J. 2000: Thymic function and T-cell differentiation in rheumatoid arthritis. Immunology 101(Suppl 1): 127

Goronzy, J.J.; Weyand, C.M. 2001: Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends in Immunology 22(5): 251-255

McCune, J.M. 1997: Thymic function in HIV-1 disease. Seminars in Immunology 9(6): 397-404

Elder, M.E.; Wara, D.W.; Sehnert, A.J.; White, C.; Harris, J.M. 2003: Thymic function in chromosome 22q112 deletion syndrome. Pediatric Research 53(4 Part 2): 14A

Ruiz Mateos, E.; Molina, S.; Rubio, A.; De La Rosa, R.; Sanchez Quijano, A.; Lissen, E.; Leal, M. 2003: Thymic function is impaired in adult hepatitis C virus co-infected patients on HAART. Journal of Hepatology 38(Suppl 2): 118

Gill, J.; Malin, M.; Sutherland, J.; Gray, D.; Hollander, G.; Boyd, R. 2003: Thymic generation and regeneration. Immunological Reviews 195: 28-50

Esparza, J.A. Reyes; Martinez, L.O.; Martinez, M.R.; Lopez, A.Q.; Bustamante, O.M.; Farina, G.G.; Fragoso, L.R. 2003: Thymic humoral factor modulates PHA-induced cutaneous hypersensitivity responses in C57BL/6 mice. FASEB Journal 17(4-5): Abstract 407

Dobhan, R.R.; Devereaux, C.E. 2000: Thymic hyperplasia associated with alpha interferon therapy. American Journal of Gastroenterology 95(9): 2570

Lovell, M.A.; Karns, L.B.; Ferguson, J.E.; Buck, M.L.; Wilson, W.G. 1999: Thymic hypoplasia and multiple malformations in the child of a liver transplant recipient. American Journal of Human Genetics 65(4): A333

Kecha, O.; Brilot, F.; Van Afferden, N.; Renard, C.; Martens, H.; Winkler, R.; Lefebvre, P.J.; Greiner, D.; Geenen, V. 1999: Thymic insulin-related peptides Role in T-cell development and self-tolerance. European Journal of Clinical Investigation 29(Suppl 1): 59

Kecha, O.; Winkler, R.; Martens, H.; Collette, J.; Lefebvre, P.J.; Greiner, D.; Geenen, V. 1999: Thymic insulin-related polypeptides in diabetes-prone Bio-Breeding rats. Diabetologia 42(Suppl 1): A29

Hsu, H.C.; Williams, R.W.; Geiger, H.; Shelton, B.J.; Yang, P.; Zhang, H.G.; Van Zant, G.; Mountz, J.D. 2001: Thymic involution is associated with A genetic locus on mouse chromosome 11. FASEB Journal 15(4): A312

Hsu, H.C.; Shelton, B.J.; Yang, P.A.; Zhang, H.G.; Mountz, J.D. 2001: Thymic involution is associated with genetic loci on mouse chromosomes 1 and 15. Journal of Investigative Medicine 49(1): 134A

Meyers, A.; Shah, A.; Cleveland, R.H.; Cranley, W.; Wood, B.; Sunkle, S.; Cooper, E.R. 2000: Thymic involution on plain chest radiograph and rapidly progressive disease in HIV-1-infected children. Pediatric Research 47(4 Part 2): 271A

Norway, R.M.; Crawford, P.C.; Johnson, C.M.; Mergia, A. 2001: Thymic lesions in cats infected with a pathogenic molecular clone or a replication-impaired molecular clone of feline immunodeficiency virus. FASEB Journal 15(4): A587

Marinova, T.; Angelova, P.; Christov, I. 1999: Thymic lympho-epithelial complex formation in mice with chemically-induced lymphoid leukaemia. Dokladi na B"lgarskata Akademiya na Naukite 52(1-2): 129-132

Hsueh, C.; Kuo, T.T.; Tsang, N.M.; Lin, J.N.; Yang, C.P. 2002: Thymic lymphoepithelioma-like carcinoma in children Detection of EBV encoded latent membrane protein-1 gene without 30-bp deletion. Laboratory Investigation 82(1): 312A

Prins, R.M.; Graf, M.R.; Merchant, R.E.; Black, K.L.; Wheeler, C.J. 2001: Thymic maturational defects induced by an intracranial glioma. FASEB Journal 15(5): A1202

Gery, I.; Gelderman, M.P.; Kennedy, M.C. 1999: Thymic medullary dendritic cells express retinal and lens specific antigens. IOVS Investigative Ophthalmology and Visual Science 40(4): S861

Noris, M.; Cugini, D.; Casiraghi, F.; Azzollini, N.; Moraes, L.D.V.; Mister, M.; Pezzotta, A.; Cavinato, R.; Perico, N.; Remuzzi, G. 2000: Thymic microchimerism determines the outcome of tolerizing protocols targeted at solid organ transplantation. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 667A

Kamo, I.; Tomoyasu, H.; Kikuchi, A. 2000: Thymic myoid cells induce myasthenia gravis and hyperplasia. Cell Biology International 24(12): 932

Gengler, C.; Chalabreysse, L.; Sefiani, S.; Thivolet Bejui, F. 2001: Thymic neuroendocrine carcinoma A clinicopathologic study of 5 cases. Virchows Archiv 439(3): 266

Geenen, V.; Martens, H.; Brilot, F.; Renard, C.; Franchimont, D.; Kecha, O. 2000: Thymic neuroendocrine self-antigens. Conti, Ario Author, Maestroni, Georges Journal M Author, McCann, Samuel M Author, Sternberg, Esther M Author, Lipton, James M Author, Smith, Craig C Author Annals of the New York Academy of Sciences Neuroimmunomodulation: Perspectives at the new millenium 710-723

Geenen, V.; Kecha, O. 1999: Thymic neuroendocrine self-antigens Role in T-cell development and central self-tolerance. Neuroimmunomodulation 6(6): 420

Geenen, V.G.; Martens, H.J.; Hansenne, I. 2001: Thymic neurohypophysial peptide-mediated signaling and T-cell differentiation. FASEB Journal 15(4): A313

Guyden, J.C.; Pezzano, M. 2003: Thymic nurse cells: a microenvironment for thymocyte development and selection. International Review of Cytology 223: 1-37

Patel, D.; Gooding, M.; Parrott, R.; Curtis, K.; Haynes, B.; Buckley, R.H. 2000: Thymic output after non-ablative allogeneic hematopoietic stem cell transplantation in infants with severe combined immunodeficiency. Journal of Allergy and Clinical Immunology 105(1 part 2): S264-S265

Oluwole, O.O.; DePaz, H.A.; Gopinathan, R.; Jin, M.X.; Ali, A.O.; Hardy, M.A.; Oluwole, S.F. 2001: Thymic recognition of AlloMHC peptide-primed alloreactive T cells induces specific unresponsiveness to islets. Transplantation Proceedings 33(1-2): 96

Michie, C.A.; Svensson, B.; Harris, S. 1999: Thymic regrowth reflects the stresses of birth. Pediatric Research 45(4 Part 2): 211A

Finkel, T.H.; Tseng, P.; Bluethmann, H.; Dunlap, A.; Paterson, R.K. 1999: Thymic regulation of dual TCR+ T cell production. Arthritis and Rheumatism 42(9 Suppl): S260

Baig, M.; Shukaliak, J.; Yao, K.; Kawamura, K.; Quigley, L.; Ludwin, S.; Bian, H.J.; Nagy, Z.; Muraro, P.; Martin, R.; Mcfarland, H.; Ito, K. 2001: Thymic selection of myelin basic protein-reactive T cells in dual transgenic mice expressing human-mouse chimeric T cell receptor and HLA-DR4-IE class II molecule. Human Immunology 62(Suppl 1): S36

von Boehmer, H.; Aifantis, I.; Gounari, F.; Azogui, O.; Haughn, L.; Apostolou, I.; Jaeckel, E.; Grassi, F.; Klein, L. 2003: Thymic selection revisited: how essential is it?. Immunological Reviews 191: 62-78

Manzar, S. 2001: Thymic size and chorioamnionitis in very low birth weight infants. Journal of Pediatrics 138(2): 296-297

Chevalier, P.; Diagbouga, S.; Traore, Y.; Cassel-Beraud, A.-M.; Van de Perre, P. 2002: Thymic size and muscle mass of HIV-infected asymptomatic children from Burkina Faso. Journal of Acquired Immune Deficiency Syndromes 29(4): 427-428

Ahmad, K. 1999: Thymic transplants help in DiGeorge syndrome. Lancet (North American Edition) 354(9188): 1451

Yeung, H.W.; Pandit Taskar, N.; Simon, J.; Larson, S.M. 2001: Thymic uptake in 131I whole body scan. Journal of Nuclear Medicine 42(5 Suppl): 323P

Chen, Z.K.; Metcalfe, S.M. 1999: Thymic-independent peripheral tolerance. Transplantation Proceedings 31(1-2): 802-803

Malek, T.R.; Porter, B.O.; Scibelli, P.; Yu, A.X.n 1999: Thymic-specific transgenic IL-2Rbeta expression in IL-2Rbeta-deficient mice prevents lethal autoimmunity. FASEB Journal 13(5 Part 2): A1127

Mundwiler, S.; Alberto, R. 2001: Thymidine derivatives with tridentate metal-chelating units and their labeling with a 3 3+-kit. Journal of Labelled Compounds and Radiopharmaceuticals 44(Suppl 1): S494-S495

Khlgatian, M.; Hadshiew, I.; Eller, M.; Giese, H.; Vijg, J.; Gilchrest, B. 1999: Thymidine dinucleotide pre-treatment reduces DNA mutation frequency. Journal of Investigative Dermatology 112(4): 557

Lee, M.S.; Li, G.Z.; Yaar, M.; Runger, T.M.; Gilchrest, B.A. 2000: Thymidine dinucleotide protects cells against oxidative damage. Journal of Investigative Dermatology 114(4): 882

Curiel Lewandrowski, C.; Venna, S.; Eller, M.S.; Gilchrest, B.A. 2000: Thymidine dinucleotides induce expression of IL-10 in primary human keratinocytes. Journal of Investigative Dermatology 114(4): 783

Buckwalter, M.R.; Jackson, J.J.; Secrest, A.M.; Swigert, J.C.; Murray, B.K.; O'neill, K.L. 2002: Thymidine kinase 1 promoter regulation may be controlled by oncogenic transcription factors. Proceedings of the American Association for Cancer Research Annual Meeting 43: 99

Eriksson, S.; Skog, S.; Tribukait, B. 2000: Thymidine kinase TK1, peptide, corresponding antibodies and use of these in determination of tumor proliferation. Official Gazette of the United States Patent and Trademark Office Patents 1236(1)

Kieback, D.G.; Hasenburg, A.; Tong, X.W.; Rojas Martinez, A.; Nyberg Hoffman, C.; Kieback, C.C.; Kaplan, A.L.; Kaufman, R.H.; Ramzy, I.; Aguilar Cordova, E. 1999: Thymidine kinase gene therapy in ovarian cancer. European Journal of Cancer 35(Suppl 5): S34

Loeb, L.A.; Black, M.E. 2002: Thymidine kinase mutants. Official Gazette of the United States Patent and Trademark Office Patents 1262(3)

Grem, J.; Danenberg, K.; Behan, K.; Parr, A.; Young, L.; Nguyen, D.; Danenberg, P.; Drake, J.; Monks, A.; Allegra, C. 1999: Thymidine kinase, thymidylate synthase, dihydropyrimidine dehydrogenase and p53 profiles of cell lines in the National Cancer Institute anticancer drug screen. Proceedings of the American Association for Cancer Research Annual Meeting 40: 8

Sangro, B. 2001: Thymidine kinase-based gene therapy of liver cancer. Cancer Gene Therapy 8(9): 691-692

Vile, R.G. 1999: Thymidine kinases. Blankenstein, T Gene therapy: Principles and applications 247-266

Marti, R.; Spinazzola, A.; Nishino, I.; Andreu, A.L.; Naini, A.; Tadesse, S.; Oliver, J.; Hirano, M. 2001: Thymidine metabolism is altered in MNGIE. Neurology 56(8 Suppl 3): A465

Bicknell, R.; Brown, N.S.; Jones, A.; Fujiyama, C.; Harris, A.L. 2000: Thymidine phosphorylase An angiogenic enigma. Clinical and Experimental Metastasis 17(9): 740

Spinazzola, A.; Nishino, I.; Hirano, M. 1999: Thymidine phosphorylase activity is severely reduced in MNGIE. Neurology 52(6 Suppl 2): A20-A21

Ogawa, K.; Konno, S.; Ohbu, M.; Shimao, K.; Hamaguchi, K.; Murayama, M.; Wagatsuma, Y.; Shimakawa, T.; Katsube, T.; Naritaka, Y.; Yagawa, H. 2002: Thymidine phosphorylase and PCNA expression predict the recurrence due to hematogenous metastasis of gastric carcinoma. International Journal of Cancer Suppl (13): 84

Streeter, E.H.; Hutchinson, G.; Jones, A.; Harris, A.L.; Bicknell, R. 2003: Thymidine phosphorylase and bladder cancer Direct tumorigenicity in vivo and a target for anti-angiogenic therapy. Journal of Urology 169(4 Suppl): 196

Cheng, C.; Pendyala, L.; Toth, K.; Tan, D.; Xia, Z.; Petrelli, N.; Leichman, L.; Leichman, C.G.il 2002: Thymidine phosphorylase and thymidylate synthetase mRNA and protein expression in colorectal cancer. Proceedings of the American Association for Cancer Research Annual Meeting 43: 217-218

Fairbanks, L.D.; Duley, J.A.; Carrey, E.A.; Hammans, S.R.; Marinaki, A.M. 2003: Thymidine phosphorylase deficiency Deoxyuridine accumulation in urine. Journal of Inherited Metabolic Disease 26(Suppl 2): 133

Shin, S.K.; Shin, Y.; Park, S.W.; Chung, J.P.; Chung, J.B.; Kang, J.K.; Song, S.Y. 2002: Thymidine phosphorylase expression as a useful prognostic marker in pancreatic cancer. Gastroenterology 122(4 Suppl 1): A 597

Mikami, Y.; Mikami, M.; Wajima, N.; Kawashima, H.; Suzuki, H. 2000: Thymidine phosphorylase expression in advanced gastric cancer tissue and postoperative effect of adjuvant 5-DFUR administration. Proceedings of the American Association for Cancer Research Annual Meeting 41: 802

Mauri, F.; Barbareschi, M.; Yang, Q.; Mori, I.; Muscara, M.; Caffo, O.; Galligioni, E.; Kakudo, K.; Palma, P.D.lla 2001: Thymidine phosphorylase expression in breast cancer A potential predictor of responsiveness to CMF chemotherapy. Virchows Archiv 439(3): 445

Lee, W.S.; Kim, M.; Kim, H.W.; Koh, G.H.; Lee, J.S.; Ha, W.S.; Jang, J.S. 2003: Thymidine phosphorylase expression in stomach cancer tissue Significance of matrix staining. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1071

Padrik, P.; Saar, H.; Leppik, K.; Arak, A. 2003: Thymidine phosphorylase expression in tumor cells of metastatic renal cell carcinoma patients treated with capecitabine and interferon-alfa2A. EJC Suppls 1(5): S261

Stanton, Vincent, P.Jr 2004: Thymidine phosphorylase gene sequence variances having utility in determining the treatment of disease. Official Gazette of the United States Patent and Trademark Office Patents 1284(1)

Takao, S.; Akiyama, S.I.; Nakajou, T.; You, H.; Kitazono, M.; Miyazono, F.; Matsuo, Y.; Noma, H.; Kusano, C.; Shinchi, H.; Natsugoe, S.; Aikou, T. 2000: Thymidine phosphorylase is associated with tumor invasion and metastasis Effect of its inhibitor on experimental liver metastasis. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1413

Parsels, L.A.; Parsels, J.D.; Maybaum, J. 2002: Thymidine secretion partially accounts for the non-contact-dependent component of thymidylate synthase mediated bystander protection. Proceedings of the American Association for Cancer Research Annual Meeting 43: 424

Stewart, D.; Dibas, A.; Anwar, S.; Howard, J.; Khan, A. 2000: Thymidlato-1,2-diaminocyclohexane platinum , an anti-tumor drug; a comparison with Cisplatin. FASEB Journal 14(4): A470

Aschele, C.; Lonardi, S.; Monfardini, S. 2002: Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer. Cancer Treatment Reviews 28(1): 27-47

Backus, H.H.J.; Van Groeningen, C.J.; Bloemena, E.; Dukers, D.; Pinedo, H.M.; Peters, G.J. 2001: Thymidylate synthase , Ki67 and RB expression are higher in colorectal liver metastases than in primary tumors. Proceedings of the American Association for Cancer Research Annual Meeting 42: 613

Kornmann, M.; Link, K.; Sander, S.; Kron, M.; Straeter, J.; Schwabe, W.; Haeussler, P.; Behnke, D.; Beger, H. 2001: Thymidylate synthase and dihydropyrimidine dehydrogenase expression in stage II and III colorectal cancer patients receiving adjuvant 5-fluorouracil. European Journal of Cancer 37(Suppl 6): S300-S301

Berglund, A.; Edler, D.; Nordlinder, H.; Molin, D.; Graf, W.; Glimelius, B. 2001: Thymidylate synthase and p53 expression do not predict chemotherapy outcome in metastatic colorectal carcinoma. European Journal of Cancer 37(Suppl 6): S290

Dolnick, B.J. 2000: Thymidylate synthase and the cell cycle: what should we believe?. Cancer Journal 6(4): 215-216

Foekens, J.A.; Romain, S.; Bolt, D.V.ies, J.; Look, M.P.; Meijer Van Gelder, M.E.; Martin, P.M.; Klijn, J.G.M. 1999: Thymidylate synthase and thymidine kinase activities are opposite predictive factors for response to tamoxifen therapy in recurrent breast cancer. Proceedings of the American Association for Cancer Research Annual Meeting 40: 492

Tommasi, S.; Montemurro, S.; Lacalamita, R.; Marzullo, F.; Giuliani, F.; Colucci, G.; Paradiso, A. 2000: Thymidylate synthase and thymidine phoshorylase expression in human gastric cancer. International Journal of Biological Markers 15(3): 275

Zhang, J.; Rose, J.R.; Butler, W.M.; Berger, S.H.bert 2003: Thymidylate synthase as a candidate marker of tumor grade in breast tumors. Proceedings of the American Association for Cancer Research Annual Meeting 44: 881

Li, Q.; Sergeeva, M.; Boyer, C.; Lee, J.; Lackey, D.; Shepard, H.M.chael 2000: Thymidylate synthase catalyzes generation of cytotoxic species preferentially inside tumor cells. Proceedings of the American Association for Cancer Research Annual Meeting 41: 5-6

Varzim, G.; Santos, L.; Salgueiro, N.; Veiga, I.; Fragoso, M.; Sousa, O.; Tavares, A.; Lopes, C.; Sanches, E.; Dos Santos, J.G.imaraes 2001: Thymidylate synthase expression and TS gene polymorphism in colorectal cancer Implications on therapeutic response to 5-FU. European Journal of Cancer 37(Suppl 6): S298

Cuatrecasas, M.; Dotor, E.; Pareja, L.; Navarro, M.; Moreno, V.; Murcia, C.; Capella, G. 2003: Thymidylate synthase expression correlates with survival in colorectal carcinomas A preliminary Study. Modern Pathology 16(1): 116A

Williams, A.W.; Chadee, A.; Berger, S. 2003: Thymidylate synthase expression in human R163K and M190K using a monoclonal antibody. Abstracts of Papers American Chemical Society 225(1-2): CHED 986

Corsi, D.C.; Martini, M.; Specchia, M.; Zannoni, G.; Maggiano, N.; Mancini, M.; Pozzo, C.; Barone, C. 1999: Thymidylate synthase expression in resected metastasis of colorectal cancer. FASEB Journal 13(7): A1534

Hu, Y.C.; Komorowski, R.; Graewin, S.; Pitt, H.A.; Ahrendt, S.A. 2003: Thymidylate synthase expression predicts the response to 5-FU based adjuvant therapy in pancreatic cancer. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1275-1276

Marsh, S.; Mcleod, H.L. 2000: Thymidylate synthase gene amplification in colorectal cancer. Proceedings of the American Association for Cancer Research Annual Meeting 41: 752

Grivicich, I.; Passos, D.T.; Peters, G.J.; Da Rocha, A.B.; Kayser, G.B.; Schwartsmann, G.; Mans, D.R.A. 2002: Thymidylate synthase gene expression and cell cycle phase distribution after irinotecan administration Implications for the synergistic effect of sequential irinotecan/5-fluorouracil in the HT-29 human colon carcinoma cell line. Proceedings of the American Association for Cancer Research Annual Meeting 43: 258

Stanton, Vincent, P.Jr 2003: Thymidylate synthase gene sequence variances having utility in determining the treatment of disease. Official Gazette of the United States Patent and Trademark Office Patents 1277(3)

Cassidy, J. 2000: Thymidylate synthase inhibitors in colorectal cancer. Seminars in Oncology 27(5 Suppl 10: 83-87

Hillenbrand, A.; Formentini, A.; Staib, L.; Danenberg, K.; Danenberg, P.; Kornmann, M. 2003: Thymidylate synthase is a predictor for response and survival of patients with isolated unresectable liver tumors receiving hepatic artery infusion chemotherapy. EJC Suppls 1(5): S72

Kommann, M.; Schwabe, W.; Haeusler, P.; Straeter, J.; Polat, S.; Behnke, D.; Beger, H.G.; Link, K.H. 2001: Thymidylate synthase predicts disease-free survival in stage IIb and III colon and stage II and III rectal cancer receiving adjuvant 5-FU chemotherapy. Journal of Cancer Research and Clinical Oncology 127(Suppl 1): S81

Zinzindohoue, F.; Ferraz, J.M.; Laurent-Puig, P. 2001: Thymidylate synthase promoter polymorphism. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 19(14): 3442

Cascinu, S.; Aschele, C.; Barni, S.; Debernardis, D.; Baldo, C.; Tunesi, G.; Catalano, V.; Staccioli, M.P.; Brenna, A.; Muretto, P.; Catalano, G. 1999: Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(8): 1996-1999

Marsh, S.; Curran, S.; Mckay, J.A.; Cassidy, J.; Mcleod, H.L. 2001: Thymidylate synthase protein expression in primary colon tumor does not predict expression in lymph node metastasis. Proceedings of the American Association for Cancer Research Annual Meeting 42: 612

Link, K.H.; Kornmann, M.; Danenberg, K.D.; Danenberg, P.V.; Beger, H.G. 2000: Thymidylate synthase quantitation and chemosensitivity testing predicts response to hepatic arterial infusion therapy. Proceedings of the American Association for Cancer Research Annual Meeting 41: 802

Kornmann, M.; Link, K.H.; Butzer, U.; Danenberg, K.D.; Sunelaitis, E.; Salonga, D.; Danenberg, P.V.; Beger, H.G. 1999: Thymidylate synthase quantitation of chemosensitivity testing predicts response and survival of patients with liver tumours receiving arterial infusion chemotherapy. European Journal of Cancer 35(Suppl 4): S194

Kornmann, M.; Schwabe, W.; Straeter, J.; Haeussler, P.; Polat, S.; Danenberg, K.; Danenberg, P.; Beger, H.; Behnke, D.; Link, K. 2001: Thymidylate synthase quantitation predicts for disease-free survival in colorectal cancer patients receiving adjuvant 5-fluorouracil. Proceedings of the American Association for Cancer Research Annual Meeting 42: 618

Bravo, Y.; Valle, N.; Oterino, A.; Castillo, J.; Pascual, J.; Ruiz Alegria, C.; Sanchez Velasco, P.; Leyva Cobian, F.; Munoz, P.; Cid, C. 2003: Thymidylate synthase tandem repeat polymorphism does not affect the risk for migraine. Cephalalgia 23(7): 665

Shirota, Y.; Nihei, Z.; Ichikawa, W.; Takahashi, T.; Aihara, A.; Morita, S.; Nishi, N.; Hirayama, R.; Miyanaga, T. 2003: Thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase-gene expression in primary gastric cancer and metastatic sites. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1001

Parsels, L.A.; Maybaum, J. 2001: Thymidylate synthase-mediated bystander protection from fluorodeoxyuridine-induced cytotoxicity is enhanced by, but does not require, direct cell-cell contact. Proceedings of the American Association for Cancer Research Annual Meeting 42: 295

Nohara, K.; Tsukumo, S.; Ito, T.; Yamamoto, M.; Motohashi, H.; Hida, A.; Fujii Kuriyama, Y.; Inouye, K.; Nagai, H.; Tohyama, C. 2003: Thymocyte alterations in CD2-driven constitutively active arylhydrocarbon receptor transgenic mice. Toxicological Sciences 72(S-1): 362

Itoh, T.; Nakamura, M.; Yagi, H.; Soga, H.; Ishii, T. 2000: Thymocyte and B-cell death without DNA fragmentation. Cameron, R G Author, Feuer, G Author Handbook of Experimental Pharmacology; Apoptosis and its modulation by drugs 375-397

Su, D.M.; Manley, N.R. 2000: Thymocyte death and growth during the CD4-8- to CD4+8+ transition in Hoxa3-Pax1 compound mutant mice. FASEB Journal 14(6): A922

Clevers, H. 2003: Thymocyte development: drama without Brahma. Immunity 19(2): 157-158

Kattman, S.J.; Lukin, K.; Oh, J.; Berg, R.E.; Staerz, U. 2003: Thymocyte fate as a function of duration and avidity of TCR/MHC/peptide interactions. FASEB Journal 17(7): C4

Farr, A.; Rubin, J.; Larochelle, W.; Erickson, M. 2000: Thymocyte-derived KGF A paracrine regulator of thymic epithelium. FASEB Journal 14(6): A916

Davey, G.M.; Schober, S.L.; Endrizzi, B.T.; Dutcher, A.K.; Jameson, S.C.; Hogquist, K.A. 1999: Thymocytes are more sensitive than T cells to peptide-MHC stimulation. FASEB Journal 13(4 Part 1): A620

Rodriguez Galan, M.C.; Young, H.A. 2003: Thymocytes can express a different cytokines and chemokines receptors profile after in vitro stimulation with interleukin-18 in combination with IL-2 or IL-12. FASEB Journal 17(7): C140

Glotz, D.; Antoine, C.; Pegaz, B.; Fornairon, S.; Duboust, A.; Bariety, J. 1999: Thymoglobulin induction nullifies the effect of cold ischemia time and delayed graft function on short and long term kidney graft survival. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 730A

Khositseth, S.; Gillingham, K.J.; Chavers, B.M. 2003: Thymoglobulin induction therapy decreases acute rejection episode in pediatric kidney transplant recipients A single center report. Journal of the American Society of Nephrology 14(Abstracts Issue): 436A

D.F.lippo, S.; Boissonnat, P.; Sassolas, F.; Ninet, J.; Robin, J.; Champsaur, G.; Bozio, A. 2002: Thymoglobuline as induction immunotherapy in pediatric heart transplantation. Journal of Heart and Lung Transplantation 21(1): 172

Zee, O.P.; Jung, Y.H.; Lee, K.R.; Moon, H.I.; Baek, H.G.; Lee, M.J.; Kim, D.K. 2001: Thymol derivatives having anti-tumor activity, and anti-cancer agent comprising the same. Official Gazette of the United States Patent and Trademark Office Patents 1248(1)

Welsh, J.S.; Bass Wilkins, K.; Green, R.; Bulkley, G.; Askin, F.B.; Diener West, M. 2000: Thymoma and neoplasia An intrinsic association. Cancer Journal 6(2): 109

Welsh, J.S. 2004: Thymoma and subsequent cancers. International Journal of Cancer 108(2): 327

Jaklitsch, M.T.; Byrne, J.G.; Mery, C. 1999: Thymoma encasing last patent vein graft to the heart. Journal of Thoracic and Cardiovascular Surgery 118(3): 561-563

Mikou, P.; Stergiou, E.; Petrakakou, E.; Papaioannou, D.; Karkabassi, A.; Athanassiadou, P.; Ioakim Liossi, A. 2002: Thymoma with positive cytology of pleural and ascitic fluid A case report. Acta Cytologica 46(1 Suppl): 184-185

Moran, C.A.; Suster, S. 2001: Thymomas with prominent adenomatoid features A clinicopathological and immunohistochemical study of 12 cases. Laboratory Investigation 81(1): 224A

Sharapova, M.H.; Nizametdinov, I.N.; Magrupov, B.A. 2002: Thymomegalia in children. Uzbekiston Tibbiet Zhurnali 4: 103-105

Morozov, V.; Khavinson, V.; Malinin, V. 2000: Thymomimetic and cytokine-like properties of L-Lys-L-Glu dipeptide. FASEB Journal 14(6): A1114

Borromei, A.; Alvisi, C.; Caramelli, R.; Cerisoli, M.; Pasini, V.; Romani, G.; Vargiu, B. 2000: Thymopentine therapy in multiple sclerosis. European Journal of Neurology 7(Suppl 3): 93

Halnon, N.J.; Plunkett, M.; Jamieson, B.D.; Belzer, M.; Church, J.; Krogstad, P. 2003: Thymopoiesis and peripheral T-cell populations in children after surgery for congenital heart disease Effects of thymectomy in infancy. Pediatric Research 53(4 Part 2): 31A

Allman, D.; Bhandoola, A. 2003: Thymopoiesis without common lymphoid progenitors. FASEB Journal 17(7): C8

Shoieb, A.; Dudrick, P. 2000: Thymoquinone arrests in vitro proliferation of canine osteosarcoma cells in the G1 phase. Proceedings of the American Association for Cancer Research Annual Meeting 41: 30

Gali Muhtasib, Hala U.; Boltze, Carsten; Diab Assaf, Mona; Al Hmaira, Josianne; Roessner, Albert; Schneider Stock, Regine 2003: Thymoquinone extracted from Blackseed is a potent growth inhibitor and inducer of apoptosis in human colon cancer HCT-116 cells. Proceedings of the American Association for Cancer Research Annual Meeting 44: 534-535

E.M.hmoudy, A.; Shimizu, Y.; Hayato, M.; Takewaki, T. 2003: Thymoquinone prevents progression of diabetes mellitus via nitric oxide inhibitory pathway. Journal of Pharmacological Sciences 91(Suppl I): 288P

Mahgoub, A.A. 2003: Thymoquinone protects against experimental colitis in rats. Toxicology Letters 143(2): 133-143

Chakravarti, A.; Zehr, E.; Zietman, A.; Shipley, W.; Finkelstein, D.; Goggins, W.; Young, R.; Wu, C.L. 1999: Thymosin B15 staining predicts for distant failure in patients with prostate cancer who are clinically M0 at presentation. International Journal of Radiation Oncology Biology Physics 45(3 Suppl): 219-220

Fan, X.L.; Xu, D.Z. 1999: Thymosin alpha1 for patients with clinically apparent cirrhosis due to chronic hepatitis B fan XL, XU DZ, Beijing Ditan Hospital, Beijing, PR China 100011. Hepatology 30(4 Part 2): 646A

Malinda, K.M.; Kleinman, H.K.; Goldstein, A.L. 2001: Thymosin alpha1 promotes tissue repair, angiogenesis and cell migration. Official Gazette of the United States Patent and Trademark Office Patents 1244(1)

Rho, S.B.; Chun, T.; Lee, S.H.; Lee, J.H. 2003: Thymosin b-10 binds E-tropomodulin and induces an apoptosis by blocking the formation of actin-binding complex. Proceedings of the American Association for Cancer Research Annual Meeting 44: 465

Hutchinson, L.M.; Kim, S.; Ushiyama, N.; Becker, C.M.; Chang, E.L.; Gaston, S.M.; Dewolf, W.C.; Zetter, B.R. 2002: Thymosin beta 15 levels in patient urine as a prognostic marker for human prostate cancer. Proceedings of the American Association for Cancer Research Annual Meeting 43: 639-640

Sosne, G.; Chan, C.C.; Thai, K.; Kennedy, M.; Kleinman, H.K. 2000: Thymosin beta 4 promotes corneal epithelial cell migration in vitro and accelerates wound healing in vivo. IOVS Investigative Ophthalmology and Visual Science 41(4): S908

Sosne, G.; Szliter, E.A.; Barrett, R.; Kernacki, K.A.; Kleinman, H.K.; Hazlett, L.D. 2001: Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali burn. IOVS Investigative Ophthalmology and Visual Science 42(4): S887

Sosne, G.; Chan, C.C.; Thai, K.; Kennedy, M.; Szliter, E.A.; Hazlett, L.D.; Kleinman, H.K. 2001: Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Experimental Eye Research 72(5): 605-608

Zolota, V.; Leondiadis, L.; Melachrinou, M.; Apostolikas, N.; Ithakissios, D.S.; Livaniou, E.; Evangelatos, G.P. 1999: Thymosin beta-10 expression in human renal tumors. Virchows Archiv 435(3): 280

Santelli, G.; Bartoli, P.C.; Mineo, A.; Barone, M.V.; Busiello, I.; Califano, D.; Fusco, A. 2001: Thymosin beta-10 synthesis suppression reduces the growth of human thyroid carcinoma cells in semisolid medium. International Journal of Molecular Medicine 8(Suppl 1): S66

Zetter, B.R.; Bao, L. 2002: Thymosin beta-15 promoter and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1265(1)

Chakravarti, A.; Zehr, E.M.; Zeitman, A.L.; Shipley, W.U.; Goggins, W.B.; Finkelstein, D.M.; Young, R.H.; Wu, C.L. 2000: Thymosin beta15 predicts for distant failure in patients with clinically localized prostate cancer. Proceedings of the American Association for Cancer Research Annual Meeting 41: 640-641

D.L.C., E.M.; Sweeney, H.L.; Safer, D. 1999: Thymosin beta4 binding and actin conformation. Biophysical Journal 76(1 Part 2): A40-A40

Wyczolkowska, J.; Czarnecki, J.; Pawlikowski, M.; Dastych, J. 2000: Thymosin beta4 induces mast cell degranulation. Immunology Letters 73(2-3): 256

Blain, E.J.; Mason, D.J.; Duance, V.C. 2002: Thymosin beta4 is mechanically regulated in articular cartilage. Biochemical Society Transactions 30(5): A104

Cha, H.J.; Webber, M.; Kleinman, H.K. 2002: Thymosin beta4 promotes tumor metastasis. Clinical and Experimental Metastasis 19(Suppl): 28

Wang, Q.R.; Huang, W.Q.; Cheng, L.M.; Wang, B.H. 2000: Thymosin beta4, a negative regulator of hematopoietic progenitors produced by bone marrow endothelial cells. Experimental Hematology 28(7 Suppl 1): 102

Farrimond, D.; Crossen, H.; Starich, G.H.; Spangelo, B.L. 2000: Thymosin fraction 5 inhibits the proliferation of the human promyelocytic leukemia HL-60 cell line in vitro. Journal of Investigative Medicine 48(1): 58A

Sanyal, Sohini; Lahousse, Stephanie A.; Sungarian, Arno; Huang, Eric; Wands, Jack R.; De La Monte, Suzanne M. 2002: Thymosin-alpha-1-mediated killing of gliosarcoma cells Potential in vivo use as an adjuvent chemotherapy agent. FASEB Journal 16(5): A1203

Lau, G.K.; Nanji, A.; Jinlin, H.; Fong, D.Y.; Yuen, S.T.; Lai, S.T.; Leung, Y.K.; Leung, S.K.; Lam, S.K. 2001: Thymosin-alpha1 and famciclovir combination therapy activates T cell response in patients with chronic HBV infection in immune tolerant phase. Hepatology 34(4 Pt 2): 324A

Chan, H.L.; Tang, J.L.; Sung, J.J. 2001: Thymosin-alpha1 for the treatment of chronic hepatitis B virus infection A meta-analysis. Gastroenterology 120(5 Suppl 1): A 573

Sugahara, S.; Ichida, T.; Yamagiwa, S.; Uehara, H.; Ishikawa, T.; Yoshida, Y.; Watanabe, H.; Abo, T.; Asakura, H. 2001: Thymosin-alpha1 increases intrahepatic natural killer T cells and cytotoxic T lymphocytes in the patients with chronic hepatitis B. Hepatology 34(4 Pt 2): 629A

Barisani Asenbauer, T.; Maca, S.; Sacu, S.; Firbas, U.; Beczak, J.; Safieh Garabedian, B. 2001: Thymulin levels in patients with uveitis. IOVS Investigative Ophthalmology and Visual Science 42(4): S571

Pinto, E.; Pina Vaz, C.; Rodrigues, A.; Salgueiro, L.; Cavaleiro, C.; Oliveira, S.; Tavares, C.; Palmeira, A.; Goncalves, M.J.; Oliveira, J. 2002: Thymus An essential oil with antifungal activity. Mycoses 45(Suppl 2): 47

Cap, J. 1999: Thymus X cremnophilus, a new hybrid taxon from Greece. Casopis Narodniho Muzea Rada Prirodovedna 168(1-4): 116

Rosenzweig, M.; Bagley, J.; Huynh, V.; Cyr, S.; Pykett, M.; Marshall, D. 2002: Thymus and Skin Stroma Support De Novo T Cell Generation in a Novel Three-Dimensional Matrix. Blood 100(11): Abstract No. 949

Kakinuma, T.; Nakamura, K.; Wakugawa, M.; Mitsui, H.; Tada, Y.; Saeki, H.; Torii, H.; Asahina, A.; Tamaki, K. 2001: Thymus and activation-regulated chemokine in atopic dermatitis Serum level of TARC is closely related with disease activity. Journal of Investigative Dermatology 117(2): 463

Fujii, M.; Hiroto, S.; Suzuki, M.; Masamichi, H. 2002: Thymus and self-unresponsiveness Cellular and molecular basis for the generation of autoimmunity in neonatally thymectomized mice. Zoological Science 19(12): 1474

Suzuki, M.; Fujii, M.; Shimada, H.; Hosono, M. 2002: Thymus and self-unresponsiveness On the generation of anti-parietal cell autoantibodies in the autoimmunity in neonatally thymectomized mice/b. Zoological Science 19(12): 1474

Durkin, H.G.; Waksman, B.H. 2001: Thymus and tolerance. Is regulation the major function of the thymus?. Immunological Reviews 182: 33-57

Mantuano, M.B.; Henriques Pons, A.; Persechini, P.M.; Coutinho, C.M.L.; Di Virgilio, F.; Araujo Jorge, T.C.; Coutinho Silva, R. 1999: Thymus atrophy in experimental T cruzi infection A possible involvement of P2X7 receptors. Memorias do Instituto Oswaldo Cruz 94(Suppl 2): 189

Yamamoto, H.; Iwao, M.; Fukada, S.; Harada, T.; Tsujikawa, K. 1999: Thymus atrophy in the laminin alpha-2 chain deficient mouse. FASEB Journal 13(4 Part 1): A621

Shimada, H.; Yoshida, M.; Hosono, M. 2000: Thymus control of the development of T cell function. Zoological Science 17: 113

Rodewald, H.R. 2000: Thymus epithelial cell reaggregate grafts. Current Topics in Microbiology and Immunology 251: 101-108

Geenen, V.; Brilot, F.; Hansenne, I.; Louis, C.; Martens, H.; Wucherpfennig, K.; Gorus, F. 2003: Thymus tolerance dysfunction in the development of the autoimmune diabetogenic response A way for a novel type of vaccine/immunotherapy. Diabetologia 46(Suppl 2): A10

Grajewski, R.S.; Silver, P.B.; Agarwal, R.K.; Chan, C.C.; Caspi, R.R. 2004: Thymus-derived CD4+CD25+ regulatory T cells set the threshold of susceptibility to Experimental Autoimmune Uveitis. FASEB Journal 18(4-5): Abstract 561

Murphy, C.; Mayrhofer, G. 1999: Thymus-independent CD4+ T-cells in nude rats Mucosal origin and relationship to NKT cells. Immunology Letters 69(1): 152

Kamal, M.; Wakelin, D.; Smith, A.; Ouellette, A.; Podolsky, D.K.; Mahida, Y.R. 2001: Thymus-independent mucosal T cells regulate the increase in Paneth and intermediate cells in the small intestine of mice infected with T spiralis. Clinical Science (London) 100(2): 13P-14P

Gubala, E.; Chmielik, E.; Handkiewicz Junak, D.; Zeman, M.; Wiench, M.; Jarzab, B. 2002: Thyreoglobin RT-PCR from FNA material in detecting lymph node metastases in the course of differentiated thyroid carcinoma. Acta Cytologica 46(1 Suppl): 105-106

Gubala, E.; Chmielik, E.; Handkiewicz Junak, D.; Zeman, M.; Wiench, M.; Jarzab, B. 2002: Thyreoglobulin RT-PCR from FNA material in detecting lymph node metastases in the course of differentiated thyroid carcinoma. Acta Cytologica 46(1 Suppl): 129

Filip, M.; Czepiel, K.; Nowak, E.; Wydra, K.; Przegalinski, E.; Lason, W. 2003: Thyreotropin-releasing hormone and cocaine sensitization in rats. European Neuropsychopharmacology 13(Suppl 4): S423

Rooman, R.P.; De Block, C.E.M.; Weyler, J.; Du Caju, M.V.L.; De Leeuw, I.H. 1999: Thyro-gastric autoimmunity in children and adolescents with type 1 diabetes. Hormone Research 51(Suppl 2): 90

De Block, C.; De Leeuw, I.; Van Campenhout, C.; Martin, M.; Decochez, K.; Gorus, F.; Belgian Diabetes Registry 2001: Thyrogastric autoimmunity in first-degree relatives of type 1 diabetic patients. Diabetologia 44(Suppl 1): A 153

Tse, W.K.; Kalkman, P.M.J.; Batstra, M.R.; Bruining, G.J.; Roep, B.O.; Aanstoot, H.J.; Drexhage, H.A. 2000: Thyrogastric disease in type 1 diabetes patients and their first degree relatives. Immunobiology 203(1-2): 531

Gubala, E.; Junak, D.H.; Zeman, M.; Chmielik, E.; Wiench, M.; Jarzab, B. 2001: Thyroglobulin RT-PCR in fine needle biopsy aspirates from neck lymph nodes for detection of differentiated thyroid cancer metastases. European Journal of Cancer 37(Suppl 6): S117

Whitley, R.J.; Ain, K.B. 2004: Thyroglobulin: a specific serum marker for the management of thyroid carcinoma. Clinics in Laboratory Medicine 24(1): 29-47

Lando, A.; Holm, K.; Nysom, K.; Rasmussen, A.K.; Madsen, M.H.; Feldt Rasmussen, U.; Muller, J. 1999: Thyroglobulin as a marker of thyroid damage after childhood cancer. Hormone Research 51(Suppl 2): 112

Savelli, G.B.; Maccauro, M.; Aliberti, G.; Baio, S.M.; Bombardieri, E. 2001: Thyroglobulin changes as a predictive value for the efficacy of thyroid remnants ablation. Journal of Nuclear Medicine 42(5 Suppl): 320P-321P

Louahed, J.; Darcaigne, D.; Denef, J.F.; Renauld, J.C.; Many, M.C. 2000: Thyroglobulin immunization induces TH1 or TH2 immune response according to the mouse genetic background. Endocrine Journal 47(Suppl August): 119

Diehl, M.; Woerdehoff, N.; Diener, J.; Menzel, C.; Gruenwald, F. 2003: Thyroglobulin increase following rhTSH administration in thyroid cancer. Journal of Nuclear Medicine 44(5 Suppl): 411P

Matos, T.; Gupta, R.; Suzuki, K.; Kohn, L.D.; Doi, S.Q.; Machado, M.O.; Sellitti, D.F. 2000: Thyroglobulin increases proliferation and regulates gene expression in mesangial cells. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 424A

Sekeroglu, M.R.; Dulger, H.; Tarakcioglu, M.; Algun, E.; Aksoy, H.; Sayarlioglu, M.; Erkoc, R.; Dilek, I.; Noyan, T. 1999: Thyroglobulin levels of endemic goiter patients living in Yumakli Village of Van, Turkey. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S194

Ringel, M.D. 2000: Thyroglobulin mRNA assays Implications for thyroid cancer management. Endocrine Journal 47(Suppl August): 92

Arvan, P. 2003: Thyroglobulin misfolding and degradation. FASEB Journal 17(4-5): Abstract 528

Arvan, P.; Park, Y.; Zhang, X.; Martin Belmonte, F.; Tokunaga, F. 2000: Thyroglobulin trafficking to the follicle lumen. Endocrine Journal 47(Suppl August): 70

Deshpande, V.; Venkatesh, S.G. 1999: Thyroglobulin, the prothyroid hormone: chemistry, synthesis and degradation. Biochimica et Biophysica Acta 1430(2): 157-178

Ghesani, N.; Zhuang, H.M.; Ponzo, F.; Alavi, A.; Mandel, S.J.; Mozley, P.D. 2001: Thyroglossal duct uptake in thyroid cancer patients undergoing pre-therapy 123I whole body scans. Journal of Nuclear Medicine 42(5 Suppl): 320P

Belicza, M.; Simunovic, D.; Cvjetko, I.; Kruslin, B.; Cupic, H.; Lechpammer, M.; Kusic, Z. 1999: Thyroid Cancer registry in Ljudevit Jurak clinical department of pathology and its connections to the National Registry of Cancer. Virchows Archiv 435(3): 253

Mushkacheva, G.S.; Rabinovich, E.I.; Preston, D.L.; Privalov, V.A.; Schneider, A.B.; Hall, P.; Povolotskaja, S.V.; Rizhova, E.F.; Masharova, E.I.; Ron, E. 2000: Thyroid abnormalities associated with protracted childhood I-131 exposure from atmospheric emissions from the Mayak Nuclear Plant in Russia. Endocrine Journal 47(Suppl August): 127

Kasztelan Szczerbinska, B.; Slomka, M.; Daniluk, J.; Lozowski, C.T.; Szczerbinski, M.; Drabko, J. 1999: Thyroid abnormalities during interferon alfa therapy for chronic hepatitis B and C. Journal of Hepatology 30(Suppl 1): 266

Johnson, A.; Abrams, G.A.; Fallon, M.B.; Langner, R.G.; Van Leeuwen, D.J.; Mcguire, B.M.; Bloomer, J.R. 2000: Thyroid abnormalities in patients with chronic hepatitis C treated with interferon-alpha and ribavirin. Hepatology 32(4 Pt 2): 558A

Abdalla, J.A. 2002: Thyroid abnormalities related to interferon beta-1a therapy. Neurology 58(7 Suppl 3): A459

Pandita, D.; Carson, P.J. 1999: Thyroid abscess caused by Mycobacterium chelonae. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 28(5): 1183-1184

Galinat, S.; Archambeaud, F.; Fronty, S.; Roger, D.; Beroud, V.; Adenis, J.P.; Teissier, M.P. 2000: Thyroid acropachy following radioiodine therapy. Endocrine Journal 47(Suppl August): 116

Shilina, S.Y.; Shilin, D.Y.; Bronstein, M.E.; Krivskaya, L.K. 2000: Thyroid adenoma in a female patient with Icenko-Cushings disease. Problemy Endokrinologii 46(6): 34-36

Rippe, V.; Belge, G.; Meiboom, M.; Bullerdiek, J. 2001: Thyroid adenomas with 19q134 aberrations Characterization of the breakpoint cluster. Experimental and Clinical Endocrinology and Diabetes 109(Suppl 1): S73

Ozkan, B.; Orbak, Z.; Döneray, H. 2000: Thyroid agenesis associated with phalangeal anomaly. Journal of Pediatric Endocrinology and Metabolism: Jpem 13(1): 99-100

Pallegrino, J.E.; Engel, J.M.; Shen Schwarz, S.; Benito, C.; Hiatt, M.; Chavez, D.; Day Salvatore, D. 1999: Thyroid agenesis in Peters anomaly - A new syndrome?. American Journal of Human Genetics 65(4): A338

Lee, J.; Cunningham Rundles, C. 2000: Thyroid amyloidosis in a patient with common variable immunodeficiency. Journal of Allergy and Clinical Immunology 105(1 part 2): S216

Paya, A.; Chulia, M.T.; Niveiro, M.; Ortega, E.; Carratala, M.D.; Segui, J. 1999: Thyroid anaplastic carcinoma Cytologic findings on 7 cases diagnosed by FNA. Virchows Archiv 435(3): 213

Cwynarski, K.; Yong, A.S.M.; Szydlo, R.M.; Apperley, J.F. 1999: Thyroid and gonadotrophin function following allogeneic BMT in men. British Journal of Haematology 105(Suppl 1): 55

Ariyaratne, H.B.S.ril; Mendis Handagama, S.M.L.C.amindrani; Mason, J.I.n 2000: Thyroid and luteinizing hormones on the onset of Leydig precursor cell differentiation. Biology of Reproduction 62(Suppl 1): 233

Grindstaff, R.D.; Pyles, R.A. 2000: Thyroid and prolactin hormones in metamorphic and paedomorphic species of ambystomatid salamanders. American Zoologist 40(6): 1035-1036

Pawlaczyk, B.; Malecka, E. 1999: Thyroid antibodies and connective tissue diseases. Hormone Research 51(Suppl 2): 141

Riano, I.; Rivas, M.F.; Enguix, A.; Lastra, B.; Fernandez, P. 2000: Thyroid antibodies in children and adolescents from a previous iodine deficient area. Hormone Research 53(Suppl 2): 110

Czerniawska, M.; Andrzejewski, W.; Teodorczyk, A.; Lawnik, M.; Mianowska, B.; Krokowski, M.; Bodalski, J. 1999: Thyroid antibodies in children with newly diagnosed type 1 diabetes. Diabetologia 42(Suppl 1): A262

Chuchan, M.R.; Amieva, C.; Miotti, A.; Bianco, M.R.; Odicino, L.; Arrieta, R. 2000: Thyroid antiperoxidase antibody studied by two techniques A correlation of results. Biocell 24(3): 311

Palazidou, E.; Bhandari, S.; Samellas, D.; Lai, M.; Botazzo, M. 2003: Thyroid auto-antibodies in Bipolar Affective Disorder Is there a link with lithium treatment?. European Neuropsychopharmacology 13(Suppl 4): S257

Bussen, S.; Suetterlin, M.; Steck, T.; Dietl, J. 1999: Thyroid autoantibodies as possible markers for reproductive failure in an in-vitro fertilization programme. Human Reproduction 14(ABSTR BOOK 1): 208

Phillips, D.; Huckle, A.; Osmond, C.; Leslie, D.; Bradbury, J.; Smith, B.R.es 2000: Thyroid autoantibodies in twins. Endocrine Journal 47(Suppl August): 187

Mclachlan, S.M. 2000: Thyroid autoantigens Overview and insight provided by analysis of the immune response to TPO. Endocrine Journal 47(Suppl August): 80

Rose, N.R.; Rasooly, L.; Saboori, A.; Burek, C.L.nne 1999: Thyroid autoimmunity The role of iodine in the etiology of thyroiditis. Journal of Autoimmunity (Suppl ): 31

Vigna, L.; Gellmann, E. 2002: Thyroid autoimmunity and function before, during and after interferon alpha-2a plus Ribavirin therapy in chronic hepatitis C. Journal of Hepatology 36(Suppl 1): 274

Lange Asschenfeldt, C.; Boor, S.; Kahaly, G.J.; Thoemke, F. 2004: Thyroid autoimmunity disorders during interferon beta-1b treatment in patients with multiple sclerosis review and case report. Nervenarzt 75(6): 589-594

Fagulha, A.; Barros, L.; Carvalheiro, M.; Ruas, M. 2000: Thyroid autoimmunity in adolescents with type 1 diabetes. Diabetes Research and Clinical Practice 50(Suppl 1): S418

Oderda, G.; Rapa, A.; Zavallone, A.; Strigini, L.; Bona, G. 2002: Thyroid autoimmunity in childhood celiac disease. Journal of Pediatric Gastroenterology and Nutrition 35(5): 704-705

Holl, R.W.; Bohm, B.; Loos, U.; Grabert, M.; Heinze, E.; Homoki, J. 1999: Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Effect of age, gender and HLA type. Hormone Research 52(3): 113-118

Bogdanos, D.P.; Okamoto, M.; Lenzi, M.; Ma, Y.; Muratori, L.; Williams, R.; Tsantoulas, D.; Bianchi, F.B.; Vergani, D. 2000: Thyroid autoimmunity in hepatitis C virus infection is genotype dependent. Hepatology 32(4 Pt 2): 370A

Karlovich, N.; Mokhort, T.; Vorontsova, T.; Garmaev, D.; Sysoeva, O. 2003: Thyroid autoimmunity in young Type 1 diabetic patients in Belarus. Diabetes and Metabolism 29(Hors serie 2): 4S90

Simonsen, H.; Villumsen, S.; Jacobsen, B.B. 2000: Thyroid biochemistry of primary neonatal screening samples in etiological subgroups of congenital hypothyroidism. Hormone Research 53(Suppl 2): 115

De Jong SA 2000: Thyroid cancer: A comprehensive guide to clinical management. Archives of Pathology and Laboratory Medicine 124(9): 1391

Prvulovic, M.; Malesevic, M.; Mihailovic, J.; Radulovic, D. 2002: Thyroid cancer MR imaging study in sixty cases. International Journal of Cancer Suppl (13): 356

Rubino, C.; Cailleux, A.F.; De Vathaire, F.; Schlumberger, M. 2002: Thyroid cancer after radiation exposure. European Journal of Cancer 38(5): 645-647

Herceg, G.H.; Brzac, H.T.; Bracic, I.; Herceg, D.; Kusacic Kuna, S.; Dodig, D. 2001: Thyroid cancer associated with Hashimoto thyroiditis. European Journal of Cancer 37(Suppl 6): S109

Vassileva, B.; Mladenova, G.M.; Iliev, D.I.; Kasakova, K.K. 1999: Thyroid cancer during childhood and adolescence in Bulgaria - 11 years after Chernobyl. Hormone Research 51(Suppl 2): 111

Hadjieva, T.; Gabrovski, R.; Pandev, R.; Vasilev, G.; Danon, S. 2001: Thyroid cancer in Bulgarian children and adolescents Prognosis and facts ten years after Chernobyl accident. European Journal of Cancer 37(Suppl 6): S339

Harabets, L.; Drozd, V.; Demidcik, Y.; Minenko, V. 2001: Thyroid cancer in children exposed to ionizing radiation in Belarus as a result of the Chernobyl accident. European Journal of Cancer 37(Suppl 6): S109

Paunkovic, N.D.; Paunkovic, J.A.; Omanovic, Z.S.; Kostic, B.K. 2000: Thyroid cancer in congenital dyshormogenitic hypothyroidism during insufficient supply of thyroxin. Endocrine Journal 47(Suppl August): 130

Antonelli, A.; Porciello, G.; Marccheroni, M.; Fallai, P.; Longombardo, G.; Storino, F.; Fadda, P.; Monti, M.; Zignego, A.L.; Ferri, C. 2000: Thyroid cancer in patients with chronic hepatitis C virus infection. Journal of Hepatology 32(Suppl 2): 108

Vovk, V.I. 1999: Thyroid cancer in precarpathian endemic goiter region. Virchows Archiv 435(3): 346

Kendall-Taylor, P. 2001: Thyroid cancer in the UK: can we do it better?. Clinical Endocrinology 54(6): 705-706

Takahashi, T.; Schoemaker, M.J.; Nakashima, N.; Trott, K.R.; Fujimori, K.; Simon, S.L.; Ohtomo, H.; Watanabe, M.; Arisawa, K.; Saito, H. 2000: Thyroid cancer prevalence in a radiation exposed population in the Marshall Islands A bomb test site. Endocrine Journal 47(Suppl August): 125

Huang, J.; Walker, R.; Groome, P.; Mackillop, W.J. 2000: Thyroid cancer risk among women after radiotherapy for breast cancer. Clinical and Investigative Medicine 23(4 Suppl): S33

Hamilton, T.E.; Kopecky, K.J.; Onstad, L.E.; Davis, S. 2000: Thyroid cancer screening by ultrasonography in a population based study Significance of large nonpalpable nodules. Endocrine Journal 47(Suppl August): 109

Kloos, R.T. 1999: Thyroid cancer whole body imaging with Tc-99m-sestamibi. Journal of Nuclear Medicine 40(5 Suppl): 132P

French, C.A.; Cibas, E.S.; Faquin, W.C.; Alexander, E.K.; Marqusee, E.; Larsen, P.R.; Fletcher, J.A.; Kroll, T.G. 2003: Thyroid cancer with PPARgamma rearrangement detected by FISH in pre-operative fine needle aspiration biopsies. Modern Pathology 16(1): 104A

Decaussin, M.; Bernard, M.H.; Tourniaire, J.; Peix, J.L.; Berger, N. 1999: Thyroid cancer with distant metastases A review of 122 cases. Virchows Archiv 435(3): 218

Straight, A.M.; Patel, A.; Fenton, C.; Dinauer, C.; Tuttle, R.M.; Francis, G.L. 2001: Thyroid cancers which express telomerase have an increased recurrence risk for children and adolescents. Pediatric Research 49(4 Part 2): 104A

Lewinski, A. 2000: Thyroid carcinoma Cytological, histopathological and genetic approach. Journal of Endocrinological Investigation 23(7 Suppl): 3

Williams, D. 2001: Thyroid carcinoma after Chernobyl. European Journal of Cancer 37(Suppl 6): S136

Williams, E.D.; Abrosimov, A.; Bogdanova, T.; Demidchik, E.P.; Ito, M.; Livolsi, V.; Lushnikov, E.; Rosai, J.; Siderov, Y.; Tronko, M.D.; Tsyb, A.F.; Vowler, S.; Thomas, G.A. 2003: Thyroid carcinoma after Chernobyl latent period, morphology and aggressivity. Journal of Pathology 201(Suppl): 12A

Ishikawa, Y.ichi 2001: Thyroid carcinoma and bone sarcoma in Werner syndrome. Goto, Makoto Author, Miller, Robert W Author Gann Monograph on Cancer Research From premature gray hair to helicase-Werner Syndrome: Implications for aging and cancer 77-82

Cetta, F.; Gori, M.; Montalto, G.; Zuckermann, M.; Santoro, G.; Baldi, C.; Acquaviva, A.; Morgese, G. 2000: Thyroid carcinoma and hepatoblastoma frequently occur in FAP siblings with APC germ-line mutations at codon 1061. Gastroenterology 118(4 Suppl 2 Pt 1): A58

Niedziela, M.; Korman, E. 2002: Thyroid carcinoma in a fourteen-year-old boy with Graves disease. Medical and Pediatric Oncology 38(4): 290-291

Boztepe, H.; Tanakol, R.; Yarman, S.; Azizlerli, G.; Kapran, Y.; Terzioglu, T.; Alagol, F. 2000: Thyroid carcinoma metastatic to the skin. Journal of Endocrinological Investigation 23(7 Suppl): 38

Gembicki, M.; Arinchin, A.N.; Petrenko, S.V.; Demidchik, E.P.; Suoniu, E. 1999: Thyroid carcinoma related to the Chernobyl catastrophe. Hormone Research 51(Suppl 2): 1

Phelps, E.; Wu, P.; Bretz, J.; Baker, J.R. 2000: Thyroid cell apoptosis. a new understanding of thyroid autoimmunity. Endocrinology and Metabolism Clinics of North America 29(2): 375-388 Viii